SESSION 47 SCHEDULE
Thursday
SESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES OR CONCEPTS
x
6:50 AM - 6:55 AM Combating Bias In Medical And Vascular Studies And Therapeutic Decision Making: Why It Is Such A Big Deal And What To Do About It
  Presenter(s):Matthew T. Menard, MD  
6:56 AM - 7:01 AM Update On Remote Monitoring Of Vascular Grafts: Where Is It At And Where Is It Going
  Presenter(s):Richard F. Neville, MD  
7:02 AM - 7:07 AM New Wearable Technologies For Telemonitoring Vascular Diseases And Their Treatments: They Will Improve Care And Decrease Hospitalization And Office Visits
  Presenter(s):Celia Riga, MD, FRCS  
7:08 AM - 7:13 AM Value Of Digital Health In Vascular Disease Management: Virtual And Otherwise
  Presenter(s):Tony S. Das, MD  
7:14 AM - 7:19 AM Vascular Surgical Risks Of Shoulder Reconstructive Surgery: What Are They And How Should They Be Managed
  Presenter(s):Jacques Busquet, MD  
7:20 AM - 7:25 AM Why Carotid Plaque Morphology Differ In Patients With An Acute MI And Those With Intermittent Claudication: Why It Matters
  Presenter(s):Henrik Sillesen, MD, DMSc  
7:26 AM - 7:31 AM Panel Discussion
7:31 AM - 7:36 AM Relining Occluded Vein Grafts With Viabahn (Gore) Stent-Grafts Or Supera (Abbott) Bare Stents Can Restore Patency And Avoid Thrombolysis: Techniques And Results
  Presenter(s):Hans Lindgren, MD, PhD  
7:37 AM - 7:42 AM Measuring Aortic Diameters Is Inaccurate And Subjective: Even With Newer Imaging Technology, One Can Make The Diameter What You Want: What Are The Implications
  Presenter(s):Janet T. Powell, MD, PhD  
7:43 AM - 7:48 AM The Temporary Perfuse Dual Chamber Stent-Graft For Clamp Free Aortic Surgery, Drug Delivery And Other Uses: How Does It Work
  Presenter(s):Bryan W. Tillman, MD, PhD  
7:49 AM - 7:54 AM Provider Skill Is Not Getting Appropriate Attention In The Health Care Value Equation Of Value = Outcome/Cost: What To Do About It
  Presenter(s):Lars B. Lonn, MD, PhD  
7:55 AM - 8:00 AM Non-Compliant Endografts For TEVAR Have A Detrimental Effect On Systolic Blood Pressure And Cardiac Function; Compliant Endografts Are The Remedy
  Presenter(s):Juan C. Parodi, MD  
8:01 AM - 8:06 AM Update On Isolated Limb Perfusion To Enable Amputated Limb Reimplantation
  Presenter(s):Zachary M. Arthurs, MD  
8:07 AM - 8:12 AM Panel Discussion
END OF SESSION 47
 
SESSION 48 SCHEDULE
Thursday
SESSION 48: PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
Moderators:James F. McKinsey, MD / TBD  
x
8:12 AM - 8:17 AM Lower Extremity Ischemic Complications After F/B/EVAR: Etiology And How To Avoid Them
  Presenter(s):Thomas S. Maldonado, MD  
8:18 AM - 8:23 AM F/B/EVAR Treatment Of FAILED EVAR: A Safer Better Way To Treat: How Has The Aortic Research Consortium Helped To Promote Solutions To This And Other Problems
  Presenter(s):Andres Schanzer, MD  
8:24 AM - 8:29 AM When Is Ch/EVAR Indicated And Equally Effective To F/EVAR For Juxta And Pararenal AAAs In Terms Of Outcomes And Cost: Why Are Opinions On Ch/EVAR So Divergent
  Presenter(s):Konstantinos P. Donas, MD  
8:30 AM - 8:35 AM Fenestrated EVAR: Techniques And Outcomes With Physician Modification And Their Impact On A New IDE Pivotal Study
  Presenter(s):Benjamin W. Starnes, MD  
8:36 AM - 8:41 AM Mortality From Aneurysm Rupture While Waiting For A Customized F/B/EVAR Endograft: Strategy To Prevent: Are There Reasons For Open Repairs In A High Volume F/B/EVAR Center
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
8:42 AM - 8:47 AM Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A US Perspective
  Presenter(s):Mark A. Farber, MD  
8:48 AM - 8:53 AM Why Balloon Expandable Bridging Stents-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A European Perspective
  Presenter(s):Mauro Gargiulo, Professor  
8:54 AM - 8:59 AM What Is The Best Bridging Covered Stent (Stent-Graft) For F/B/EVAR Based On An In Vitro Fatigue Testing Model And Other Considerations
  Presenter(s):Martin J. Austermann, MD  
9:00 AM - 9:05 AM With Complex AAAs, When F/B/EVAR; When Parallel Grafts; When Open Repair: All Have Their Pros And Cons
  Presenter(s):Chang Shu, MD  
9:06 AM - 9:11 AM Technical Tips For F/B/EVAR Repairs Of TAAAs Complicating TBADs
  Presenter(s):Götz M. Richter, MD, PhD  
9:12 AM - 9:17 AM How To Safely And Effectively Treat TAAAs With Off-The-Shelf (OTS) Devices Including Chimney And Sandwich Stent-Grafts: The Docking Station Approach: How To Do It And Midterm Results
  Presenter(s):Manish Mehta, MD, MPH  
9:18 AM - 9:26 AM Panel Discussion
9:26 AM - 9:38 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 48
 
SESSION 49 SCHEDULE
Thursday
SESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
x
9:38 AM - 9:43 AM Percutaneous Femoral And Axillary Access For Complex Endovascular AAA Repair: How To Safely Do It Safely And To Downsize Femoral Sheaths To Restore Lower Extremity Flow
  Presenter(s):Darren B. Schneider, MD  
9:44 AM - 9:49 AM Present Status Of Parallel Grafts For Complex AAAs And TAAAs: How To Do These Repairs Safely And Effectively: Results To Date
  Presenter(s):Armando C. Lobato, MD, PhD  
9:50 AM - 9:55 AM Value And Advantages Of Preloaded Wires And Catheters For F/B/EVAR: How Do They Work; Are There Pitfalls
  Presenter(s):Mark A. Farber, MD  
9:56 AM - 10:01 AM DEBATE: The Case Against Ch/EVAR And Parallel Grafts For Complex AAA And TAAA Repairs: F/B/EVAR Is Much Better
  Presenter(s):Adam Beck, MD  
10:02 AM - 10:07 AM DEBATE: Nonsense! Ch/EVAR And Parallel Grafts If Done Right Are As Safe And Effective As F/B/EVAR And In Some Cases Better And Cheaper
  Presenter(s):Edward Y. Woo, MD  
10:08 AM - 10:13 AM F/EVAR Is Sometimes Justified In Patients >80: How About >90
  Presenter(s):Clark J. Zeebregts, MD, PhD  
10:14 AM - 10:19 AM DEBATE: Increasing The Number Of Fenestrations In F/EVAR Beyond 2 Improves Outcomes Without Increasing Downsides
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
10:20 AM - 10:25 AM DEBATE: Not So! 2 Branch F/EVAR Is Sometimes Better And Has Fewer Complications And Downsides In Some Cases: Which Ones
  Presenter(s):Timothy A. Resch, MD, PhD  
10:26 AM - 10:31 AM Technical Tips To Deploy F/EVAR Endografts Precisely With Tortuous Anatomy: How To Compensate For Endograft Rotation And Still Match Fenestrations To Branch Orifices Perfectly
  Presenter(s):Bjõrn Sonesson, MD, PhD  
10:32 AM - 10:37 AM Advantages Of Steerable (Variable Curve) Sheaths For Complex AAA And TAAA Repairs And TBADs: Which One Is Best And Why: Pitfalls And How To Prevent Them
  Presenter(s):W. Anthony Lee, MD  
10:38 AM - 10:43 AM Technical Tips And Precautions For Using Steerable (Variable Curve) Sheaths For B/EVAR: Why They May Not Work And How To Make Them Work
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
10:44 AM - 10:52 AM Panel Discussion
END OF SESSION 49
 
SESSION 50 SCHEDULE
Thursday
SESSION 50: A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
x
10:52 AM - 11:03 AM The Vietnam Battle Of Ia Drang (November 14-16, 1965): Why Was It Fought And Why Was It Significant (11-Minute Talk)
  Presenter(s):Wayne F. Yakes, MD  
11:04 AM - 11:09 AM Department of Defense Effort To Support Vascular Surgery Research And US National Preparedness For Mass Casualties
  Presenter(s):Todd E. Rasmussen, MD, FACS  
11:10 AM - 11:15 AM Update On Endovascular Resuscitation And Control Of Bleeding: What Is New And Different: What Is The EVTM Society
  Presenter(s):Tal M. Hoerer, MD, PhD  
11:16 AM - 11:21 AM Update On Civilian REBOA (Resuscitative Endovascular Balloon Occlusion Of The Aorta) For Treatment Of Hemorrhage And Trauma: What Is New And Different: When And Where Should It Be Used And By Whom
  Presenter(s):Joseph J. DuBose, MD  
11:22 AM - 11:27 AM Is REBOA A Panacea For Battlefield Hemorrhage Or Not Yet Ready For Prime Time Use
  Presenter(s):Brandon Propper, MD / Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS  
11:28 AM - 11:33 AM Current Advances In The Treatment Of Blast And High Velocity Gun Shot Injuries
  Presenter(s):Paul W. White, MD  
11:34 AM - 11:39 AM Update On The Retrievable Rescue Stent Graft To Control Massive Aortic Or Caval Bleeding: How Does It Work And Present Status
  Presenter(s):Bryan W. Tillman, MD, PhD  
11:40 AM - 11:45 AM Major Amputation Prosthetics Can Be Fixed Into Bone: How Does Osteointegration Work And How Is Infection Avoided
  Presenter(s):Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS  
11:46 AM - 11:51 AM Update On Tissue Engineered Biological Arterial Grafts (Humacyte): How Well Are They Working In Patients And In What Vascular Bed
  Presenter(s):Jeffrey H. Lawson, MD, PhD  
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 50
 
SESSION 51 SCHEDULE
Thursday
SESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
x
1:00 PM - 1:05 PM Value, Limitations And Technical Tips For Using The Nellix Endograft For Ruptured AAAs
  Presenter(s):Tal M. Hoerer, MD, PhD  
1:06 PM - 1:11 PM The Incidence Of Ruptured AAAs Is Decreasing And So Is Their Mortality: Why Are These 2 Facts So
  Presenter(s):Ross Milner, MD  
1:12 PM - 1:17 PM Statins Decrease The Growth Rate And Rupture Risk Of AAAs As Well As The Perioperative Mortality: Who Should Receive Them, When And At What Dose
  Presenter(s):Thomas L. Forbes, MD  
1:18 PM - 1:23 PM Impact Of Weekends On Treatment Method (Endo Versus Open Repair) And Outcomes (Early And Late) Of Treatment For Ruptured AAAs
  Presenter(s):Sebastian E. Debus, MD, PhD  
1:24 PM - 1:29 PM Long-Term Results Of The AJAX RCT Comparing EVAR With Open Repair For Ruptured AAAs: EVAR Wins In The End – Especially In Patients >80
  Presenter(s):Willem Wisselink, MD  
1:30 PM - 1:35 PM Variation In Use Of EVAR Versus Open Repair For Ruptured AAAs Depends On Training And Bias Rather Than Data Logic Or Facts: EVAR Is Clearly The Best Treatment If It Can Be Done
  Presenter(s):Martin Malina, MD, PhD  
1:36 PM - 1:41 PM EVAR Should Be The Standard Of Care For Most Ruptured AAAs: Reasons Why It Is Not So And How To Overcome Them
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
1:42 PM - 1:47 PM EVAR Is A Better Treatment For Ruptured AAAs Than Open Repair In Most Patients: The Mortality Benefit Of EVAR Is Increasing More Recently: Based On A Meta-Analysis
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
1:48 PM - 1:53 PM DEBATE: With Ruptured Complex AAAs And TAAAs, Off-The-Shelf F/B/EVAR Is The Best Treatment
  Presenter(s):Mark A. Farber, MD  
1:54 PM - 1:59 PM DEBATE: Not So: With Ruptured Complex AAAs And TAAAs Parallel Grafts Are Simpler, More Effective And Less Costly
  Presenter(s):Konstantinos P. Donas, MD  
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 51
 
SESSION 52 SCHEDULE
Thursday
SESSION 52: MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
x
NEW DEVELOPMENTS IN AAA SCREENING
2:06 PM - 2:11 PM Why The Current US PSTF Guidelines For AAA Screening Are Insufficient: Many At Risk Patients Are Not Screened
  Presenter(s):Malachi Sheahan, MD  
2:12 PM - 2:17 PM Update On Current Screening For AAAs In The US: Most Ruptured AAAs Occur In Patients Not Being Screened: How Should US PSTF Recommendations Be Changed
  Presenter(s):Marc L. Schermerhorn, MD  
2:18 PM - 2:23 PM Flaws In AAA Screening In Finland Result In AAA Ruptures In Patients Too Young For Screening And Whose AAAs Are Too Small To Reach Threshold For Repair
  Presenter(s):Maarit Venermo, MD, PhD  
2:24 PM - 2:29 PM Why AAA Screening Should Be Expanded To More Females, Younger Men And Older Men
  Presenter(s):Thomas F.X. O'Donnell, MD  
MORE ABOUT AAA RUPTURES AND THEIR TREATMENT
2:30 PM - 2:35 PM AAA Rupture After EVAR Behaves Differently From De Novo Rupture: How Should Treatment Be Modified In Patients With Post EVAR Ruptures
  Presenter(s):Piotr Szopinski, MD, PhD  
2:36 PM - 2:41 PM Update On Treating All (100%) Ruptured AAAs With EVAR: The Orebro And Zurich Experience Shows It Is The Best Treatment And Lowers The Turndown Rate
  Presenter(s):Mario L. Lachat, MD / Thomas Larzon, MD, PhD  
2:42 PM - 2:47 PM Experience With Cook t-Branched OTS Endograft To Treat Ruptured Pararenal AAAs And TAAAs: Advantages, Limitations And Results
  Presenter(s):Ciro Ferrer, MD, PhD / Rocco Giudice, MD  
2:48 PM - 2:53 PM In Situ Laser Fenestration To Facilitate Endograft Treatment Of Ruptured TAAAs: When Is It Needed; How To Do It And Results
  Presenter(s):Stephan Haulon, MD / Dominique Fabre, MD, PhD  
2:54 PM - 2:59 PM Open Repair For AAAs Should Not Be Used In Patients >80 Unless Their AAA Is >6 cm And They Are At Risk Of Rupture Or Ruptured: These Restrictions Do Not Apply To EVAR
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
3:00 PM - 3:05 PM When Should Ruptured AAA Patients Be Transferred: Should They Ever Be Denied Invasive Treatment
 
3:06 PM - 3:11 PM Update On Advances In Treatment Of Abdominal Compartment Syndrome Associated With Ruptured AAAs: When And How To Treat Medically And When And How To Treat With Opening The Abdomen
  Presenter(s):Martin Bjorck, MD, PhD  
3:12 PM - 3:20 PM Panel Discussion
3:20 PM - 3:30 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 52
 
SESSION 53 SCHEDULE
Thursday
SESSION 53: EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
x
3:30 PM - 3:35 PM The No Intervention Option For Treatment Is More Commonly Elected For Women Than Men With CLTI, AAAs, Ruptured AAAs And Thoracic Aneurysms: It Is Wrong Headed And Unfair
  Presenter(s):Janet T. Powell, MD, PhD  
3:36 PM - 3:41 PM Transradial Approaches For Complex Lower Extremity Interventions: CTSOs, Iliac, Fempop And BTK Lesions Can Be Treated: How To Make Them Work And Precautions: Advantages Of The Terumo R2P System
  Presenter(s):David O'Connor, MD  
3:42 PM - 3:47 PM Transcatheter Bariatric Embolotherapy: Early And Long-Term Results From A Randomized Study
 
3:48 PM - 3:53 PM The Spur Stent System (Reflow Medical): A Temporary Stent With Pins To Penetrate The Arterial Wall And Facilitate DCB Drug Delivery: How Does It Work And Results To Date
  Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD / Andrew Holden, MBChB / Thomas Zeller, MD  
3:54 PM - 3:59 PM The Serranator Balloon Catheter (From Cagent Vascular) For Vessel Prep In BTK Arteries: It Makes Microserrations And Prevents Dissections With PTA: Current Status: The PRELUDE BTK Trial
  Presenter(s):Andrew Holden, MBChB  
4:00 PM - 4:05 PM What Is The OR Black Box System For Measuring Endovascular Operator Performance: How Does It Work And Should It Be In Every Hybrid Angio Suite
  Presenter(s):Isabelle Van Herzeele, MD, PhD  
4:06 PM - 4:11 PM Update On A Clampless Sutureless Technique For Performing Aorto-Iliac Anastomosis Using Endograft Connectors: The VORTEC Technique – Useful When Arterial Control And Suturing Is Impossible
  Presenter(s):Mario L. Lachat, MD  
4:12 PM - 4:17 PM Technical Tips For Safe Endovascular Treatment Of Hepatic Artery Stenosis After Liver Transplantation
  Presenter(s):W. Charles Sternbergh III, MD  
4:18 PM - 4:23 PM Current Status Of Left Gastric Embolization To Treat Obesity: Where Is It And What Will Its Role Be
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
4:24 PM - 4:29 PM The Many Possible Uses Of Femoral Veins For Arterial Procedures: How To Harvest Them Safely
  Presenter(s):Timur P. Sarac, MD  
4:30 PM - 4:38 PM Panel Discussion
END OF SESSION 53
 
SESSION 54 SCHEDULE
Thursday
SESSION 54: PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
x
PROGRESS IN RADIATION SAFETY
4:38 PM - 4:43 PM Endovascular Team Radiation Safety Performance: How To Monitor It: It Is More Than Dose Measurement
  Presenter(s):Isabelle Van Herzeele, MD, PhD  
4:44 PM - 4:49 PM Myths And Facts Regarding Radiation Protection And Safety
  Presenter(s):Lindsay Machan, MD  
4:50 PM - 4:55 PM What Is New In Radiation Safety: ESVS Radiation Safety Guidelines And Why Chromosomal Aberrations In High Volume Endovascular Operators Matters
  Presenter(s):Bijan Modarai, PhD, FRCS  
4:56 PM - 5:01 PM Simple Radiation Protection Techniques For All Interventionalists To Use
  Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR  
5:02 PM - 5:05 PM Panel Discussion
NEW CONCEPTS, ETC.
5:05 PM - 5:10 PM With Esophageal Cancer, When Is Prophylactic TEVAR Indicated To Prevent An Aorto-Esophageal Fistula
  Presenter(s):I-Hui Wu, MD, PhD  
5:11 PM - 5:16 PM Endovascular Emergency Treatment Of Carotid Blowout From Head And Neck Cancer Or Carotid Patch Infections: Planning, Preparation And Technical Tips Are Essential
  Presenter(s):Michael B. Silva, Jr., MD  
5:17 PM - 5:22 PM Value Of Repetitive Digital Photo Documentation Of The Ischemic Foot: It Improves Decisions And Outcomes
  Presenter(s):Martin Malina, MD, PhD  
5:23 PM - 5:28 PM Minimizing Contrast Induced Nephropathy With EVAR By Contrast Dilution
  Presenter(s):Naoki Fujimura, MD, PhD  
5:29 PM - 5:34 PM Current Status Of AFX-3 And Ovation (With Anatomy Adaptive Sealing) Endografts (Both From Endologix) For AAA Repairs: Advantages And Limitations Of Each
  Presenter(s):Francesco Speziale, MD / Pasqualino Sirignano, MD  
5:35 PM - 5:40 PM COVID-19 Virus Has Been Identified In Periaortic Fat: What Is Its Significance
 
5:41 PM - 5:54 PM Panel Discussion
End of Program G

END OF SESSION 54
 
SESSION 55 SCHEDULE
Thursday
SESSION 55: NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR (5-MINUTE TALKS)
x
6:50 AM - 6:55 AM Treo Endograft (From Terumo Aortic) For Standard Infrarenal EVAR: Approval In US And Japan
  Presenter(s):Matthew J. Eagleton, MD  
6:56 AM - 7:01 AM Real World Outcomes With The TREO Endograft (Terumo Aortic): Preliminary Results From The TIGER Registry
  Presenter(s):Vicente Riambau, MD, PhD  
7:02 AM - 7:07 AM Status In The US Of The Gore Conformable Excluder With Variable Neck Angulation Control For AAAs With Imperfect Necks
  Presenter(s):Robert Y. Rhee, MD  
7:08 AM - 7:13 AM Status Of The Gore Conformable Excluder For EVAR In Europe: Results From The EXCEL And BSET Registries
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD / Colin D. Bicknell, MD, FRCS  
7:14 AM - 7:19 AM When Does The Gore Conformable Excluder For EVAR Really Make A Difference: How Does It Work
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
7:20 AM - 7:25 AM Altura Endograft With Kissing Proximal Stents For Standard EVAR: Advantages And Limitations: From An Experience With 150 Patients And Up To 5-Year Follow-Up
  Presenter(s):Dainis K. Krievins, MD  
7:26 AM - 7:31 AM Advantages And Limitations Of The Cook ZENITH Alpha Endograft For EVAR: Based On European Multicenter Experience
  Presenter(s):Philippe W.M. Cuypers, MD, PhD / Marc R.H.M. van Sambeek, MD, PhD  
7:32 AM - 7:38 AM Panel Discussion
7:38 AM - 7:43 AM How And Why Do The Endurant Endograft Results For EVAR In France Differ From The Global Results: What Are The Implications
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
7:44 AM - 7:49 AM AAA Repairs With The Endurant Endograft Outside The IFU Can Provide Acceptable Results In Some Patients: When Is This So And When Not
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
7:50 AM - 7:55 AM Head To Head Comparison Of Endurant And Excluder Endografts For EVAR In Challenging Asian AAA Anatomy
  Presenter(s):Naoki Fujimura, MD, PhD  
7:56 AM - 8:01 AM Update LEOPARD RCT Results Show That AFX Endografts Compare Favorably To Standard Proximally Fixed Endografts For AAA Repair
  Presenter(s):Christopher J. Kwolek, MD, MBA  
8:02 AM - 8:07 AM AFX Endografts Work Well In Conical (Flared) AAA Necks: Why And Results
  Presenter(s):Naoki Fujimura, MD, PhD  
8:08 AM - 8:14 AM Panel Discussion
END OF SESSION 55
 
SESSION 56 SCHEDULE
Thursday
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR
x
8:14 AM - 8:19 AM Alto Endograft (From Endologix) For Standard EVAR: This Latest Modification Of The Ovation Endograft Has More Proximal Polymer Sealing Rings: Results From The ELEVATE Trial And 3-4-Year Results From The New Zealand Experience Show Advantages
  Presenter(s):Sean P. Lyden, MD / Andrew Holden, MBChB  
8:20 AM - 8:25 AM Combination Of Ovation Endograft And Bare Metal Renal Stent For Difficult AAA Neck Unsuitable For F/EVAR
  Presenter(s):Gianmarco de Donato, MD  
8:26 AM - 8:31 AM Experience With The Nellix Endograft In 120 Patients With Up To 10 Years Follow-Up: What Is The Devices’ Future
  Presenter(s):Dainis K. Krievins, MD  
8:32 AM - 8:37 AM Current Status And Value Of Chimney EVAS (Ch/EVAS): From The ASCEND Trial Data: Status Of The CHEVAS ONE IDE Trial Of Ch/EVAS In Complex AAA Repairs
  Presenter(s):Joseph V. Lombardi, MD / Pete Holt, MD, PhD / Ian Loftus, MD / Michel M.P. Reijnen, MD, PhD  
8:38 AM - 8:43 AM Comparison Of Ch/EVAS And Ch/EVAR: When Is Ch/EVAS Indicated: Advantages And Limitations
  Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS  
8:44 AM - 8:49 AM Update On Multicenter Results With F/EVAR Using The Fenestrated Anaconda Endograft: From The Global FACT Registry: Advantages And Limitations
  Presenter(s):Clark J. Zeebregts, MD, PhD / Michel M.P. Reijnen, MD, PhD  
8:50 AM - 8:55 AM Value Of The Fenestrated Anaconda Endograft For Treating Failed EVAR
  Presenter(s):Afshin Assadian, MD  
8:56 AM - 9:01 AM Update On The Incraft Endograft For Standard Infrarenal EVAR: Is Its Low Profile An Advantage
  Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD  
9:02 AM - 9:07 AM Long-Term Outcomes Of The Cook pBranch OTS Device For F/EVAR: Advantages And Limitations
  Presenter(s):Timothy A. Resch, MD, PhD  
9:08 AM - 9:15 AM Panel Discussion
9:15 AM - 9:26 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 56
 
SESSION 57 SCHEDULE
Thursday
SESSION 57: NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
x
9:26 AM - 9:31 AM Nexus OTS Endograft From Endospan For Treating Zone 1 Lesions Of The Aortic Arch: How Does It Work And 2-Year Clinical Results: Status In The US
  Presenter(s):Andrew Holden, MBChB / Daniel G. Clair, MD  
9:32 AM - 9:37 AM Outcomes Of The Custom Relay Ascending Aorta Endograft (Terumo Aortic): The European Experience
  Presenter(s):Vicente Riambau, MD, PhD / Afshin Assadian, MD / Mo S. Hamady, MD, FRCR, EBIR, FSIR  
9:38 AM - 9:43 AM Status In The US Of The RelayBranch Investigational Device For Repair Of Aortic Arch Lesions: How Many Branches Can And Should Be Revascularized: Advantages And Limitations
  Presenter(s):Luis A. Sanchez, MD / Eric E. Roselli, MD  
9:44 AM - 9:49 AM Long-Term Safety And Durable Effectiveness Of Relay (Terumo Aortic) Scalloped Endograft For TEVAR Treatment Of Lesions In Or Near The Aortic Arch
  Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR / Jean-Marc Alsac, MD, PhD  
9:50 AM - 9:55 AM Status In The US Of The Gore Conformable CTAG Endograft With Variable Angulation Control In The Aortic Arch: How Does It Work And Advantages
  Presenter(s):Jean Bismuth, MD  
9:56 AM - 10:01 AM When And How To Use The Gore Conformable CTAG Endograft Optimally: Are There Downsides
  Presenter(s):Sukgu Han, MD  
10:02 AM - 10:07 AM Indications, Value And Limitations Of Single Branched TEVAR Devices For Revascularizing The Left Subclavian Artery: Are They Worth The Effort And Cost
  Presenter(s):Gustavo S. Oderich, MD, FACS  
10:08 AM - 10:15 AM Panel Discussion
END OF SESSION 57
 
SESSION 58 SCHEDULE
Thursday
SESSION 58: NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS (TEVAR) AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS (ALL TALKS ARE 4 ¾-MINUTES)
x
DEVICES FOR TEVAR
10:15 AM - 10:20 AM Low Profile Devices for TEVAR: Advantages And Disadvantages Based On Long-Term Results
  Presenter(s):Giovanni B. Torsello, MD  
10:20 AM - 10:25 AM 6-Year Experience With The Cook ZENITH Alpha Thoracic Endograft For TEVAR In 400 Patients: How To Achieve Long-Term Durably Good Results
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
10:25 AM - 10:30 AM Long-Term Outcomes Of TEVAR For Repair Of Traumatic Aortic Injuries From The RESCUE U.S. IDE Clinical Trial
  Presenter(s):Ali Azizzadeh, MD  
10:30 AM - 10:35 AM Endoanchors To Improve Outcomes With TEVAR: They Can Help Distally As Well As Proximally
  Presenter(s):Ross Milner, MD  
10:35 AM - 10:40 AM Tips And Tricks Of Endoanchors Application After TEVAR (TESAR)
  Presenter(s):Giovanni Tinelli, MD, PhD / Yamume Tshomba, MD  
10:40 AM - 10:46 AM Panel Discussion
10:46 AM - 10:51 AM The Relay Pro (Terumo Aortic) Endograft For TEVAR And Its Advantages In Treating TBADs: Why Is It Better Than The Older Relay Plus Device
  Presenter(s):Edward Y. Woo, MD / Steven D. Abramowitz, MD  
10:51 AM - 10:56 AM Patient Specific Custom Designed Relay Pro Endografts (Terumo Aortic): How Do They Work And What Are Their Advantages In Various Circumstances
  Presenter(s):David M. Williams, MD  
10:56 AM - 11:01 AM Relay Endografts (Terumo Aortic) For TEVAR: Why Do They Provide Better Wall Apposition For Sealing
  Presenter(s):Afshin Assadian, MD  
11:01 AM - 11:06 AM European Experience With The Gore CTAG Conformable Endograft For TEVAR With Variable Angulation Control Proximally: When And How Does It Improve Results
  Presenter(s):Vicente Riambau, MD, PhD  
11:06 AM - 11:11 AM New Polymer Filled Low Profile Endograft Device With O-Ring Sealing: How Does It Work And Why Is It Better
  Presenter(s):Piotr Szopinski, MD, PhD  
11:11 AM - 11:17 AM Panel Discussion
NEW OR IMPROVED ENDO DEVICES FOR TAAA REPAIRS
11:17 AM - 11:22 AM To Treat Complex TAAAs A Combination Of A Relay (Terumo Aortic) TEVAR And A Fenestrated Anaconda Is Best: How Are The SMA And Celiac Axis Revascularized
  Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR  
11:22 AM - 11:27 AM Status Of The Cook t-Branch OTS Endograft For TAAA Repairs: Advantages And Limitations Based On A Meta-Analysis
  Presenter(s):Nikolaos Tsilimparis, MD, PhD  
11:27 AM - 11:32 AM Experience With The Cook t-Branch OTS Endograft Device For Juxta- And Pararenal AAAs: Advantages And Limitations
  Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD  
11:32 AM - 11:37 AM Comparison Of 3 OTS Endografts For Urgent TAAA Repairs: TAMBE (Gore) Versus E-nside (Jotec) Versus t-Branch (Cook): Advantages And Disadvantages Of Each
  Presenter(s):Luca Bertoglio, MD / Germano Melissano, MD / Roberto Chiesa, MD  
11:37 AM - 11:42 AM Valiant Manifold OTS Endograft (Medtronic) Device For Repairing TAAAs: How Does It Work And Early Clinical Experience In The US
  Presenter(s):Murray L. Shames, MD  
11:42 AM - 11:47 AM Unitary Manifold Endograft System For Complex Type 4 TAAAs And Failed EVARs: How Does It Work And 2-Year Results
  Presenter(s):Patrick W. Kelly, MD  
11:47 AM - 11:52 AM Novel OTS Life Tech Endograft For TAAA Repair: How Does It Work And What Makes It Different
  Presenter(s):Ralf R. Kolvenbach, MD  
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 58
 
SESSION 59 SCHEDULE
Thursday
SESSION 59: NEW OR UPDATED INFORMATION ON BALLOON EXPANDABLE COVERED STENTS, LOWER EXTREMITY PROSTHETIC GRAFTS, BIORESORBABLE GRAFTS, PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH [SEE ALSO SESSION 28] (ALL TALKS ARE 5 MINUTES)
x
STENT-GRAFTS
1:00 PM - 1:05 PM Why Are VBX Balloon Expandable Stent-Grafts (From Gore) Different And Better Than Other Covered Stents In Various Vascular Beds
  Presenter(s):James F. McKinsey, MD  
1:06 PM - 1:11 PM Safety Of MRI Early After Deployment Of Various Covered Stents
  Presenter(s):Maria A. Ruffino, MD, EBIR  
PROSTHETIC GRAFTS
1:12 PM - 1:17 PM Final 3-Year Results Of The ZILVERPASS RCT Comparing Prosthetic PTFE Bypasses With Zilver PTX (Cook) Stents To Treat Long Fempop Lesions: Should Open Prosthetic Bypass Be Abandoned
  Presenter(s):Michel J. Bosiers, MD / Marc Bosiers, MD  
1:18 PM - 1:23 PM The 3DH Spiral Flow Prostheti Graft: Does It Prevent Neointimal Hyperplasia In Leg Bypasses Or A-V Access
  Presenter(s):Hosam F. El Sayed, MD  
1:24 PM - 1:29 PM Heparin Coated (Propaten) PTFE Grafts (Gore) Versus Autologous Vein Grafts For Bypasses To Targets Above And Below The Knee: Are The Heparin Coated Grafts Worth The Cost
  Presenter(s):David J. Dexter, MD  
1:30 PM - 1:35 PM Bioabsorbable Arterial Grafts (Xeltis Grafts): How Do They Work And What Is Their Potential
  Presenter(s):Frans L. Moll, MD, PhD  
1:36 PM - 1:41 PM Perigraft Seromas After PTFE Lower Extremity And Aortic Arterial Grafts: Frequency, Etiology And What To Do About Them
  Presenter(s):Jae S. Cho, MD  
1:42 PM - 1:47 PM Update On External Sirolimus Patch Wrap-Around For PTFE Graft Anastomoses: Do They Decrease Neointimal Hyperplasia
  Presenter(s):Sriram S. Iyer, MD, FACC  
1:48 PM - 1:54 PM Panel Discussion
END OF SESSION 59
 
SESSION 60 SCHEDULE
Thursday
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
x
1:54 AM - 1:59 AM Complications Of Atherectomy: How To Prevent Some, How To Treat The Others
  Presenter(s):Theodosios Bisdas, MD  
2:00 PM - 2:05 PM Value And Limitations Of 355 nm Auryon B-Laser™ (From AngioDynamics): It Enables Safe Crossing Of Difficult Lesions Not Crossed With A Guidewire: How Does It Work And Clinical Results
  Presenter(s):Luis R. Leon, MD, RVT, FACS  
2:06 PM - 2:11 PM Orbital And Laser Atherectomy: Indications, Advantages And Precautions With Above Knee BTK De Novo Lesions And ISR
  Presenter(s):Craig M. Walker, MD  
2:12 PM - 2:17 PM Value Of Atherectomy And DCBs: Interim Results Of The REALITY Trial
  Presenter(s):Brian G. DeRubertis, MD  
ANCILLARY TECHNIQUES
2:18 PM - 2:23 PM Value of Wingman Catheter (Reflow Medical) For Crossing Difficult Lesions: How Does It Work And Results
  Presenter(s):John R. Laird, MD  
2:24 PM - 2:29 PM Value Of New Dedicated Special Tools And Devices To Facilitate Trans-Radial Access For Lower Extremity Lesion Treatments: How Far Distally Can It Be Effective
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)  
2:30 PM - 2:36 PM Panel Discussion
NEW INFORMATION ON STENTS
2:36 PM - 2:41 PM Advantages Of Supera (Vasculomimetic – VMI) Stent For Complex Fempop Occlusive Lesions: Technical Tips: They Work Even In The Subintimal Position
  Presenter(s):Erwin Blessing, MD  
2:42 PM - 2:47 PM Value Of The Supera VMI Stent For Common Femoral Artery (CFA) Occlusive Lesions: Better Than Endarterectomy: 2-Year Results And Status Of The SUPERSURG RCT (Versus Open Surgery)
  Presenter(s):Brian G. DeRubertis, MD  
2:48 PM - 2:53 PM Value Of Multiloc Ministents To Treat Post Balloon Dissections: How Do They Work And How Do They Compare To Tacks
  Presenter(s):Thomas Zeller, MD  
2:54 PM - 2:59 PM Value And Advantages Of Eluvia DESs (Boston Scientific) For Lower Extremity Occlusive Lesions: When To Use Them And How To Optimize Their Results
  Presenter(s):Steven Kum, MD  
3:00 PM - 3:05 PM RCT Comparing A New Bare Metal Stent – Misago Versus Zilver PTX DESs For Fempop Lesions: 2-Year Results Of The BATTLE Trial: Misago Stents Can Be Deployed Via Radial Access
  Presenter(s):Yann Gouëffic, MD, PhD  
3:06 PM - 3:12 PM Panel Discussion
3:12 PM - 3:24 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 60
 
SESSION 61 SCHEDULE
Thursday
SESSION 61: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
x
3:24 PM - 3:29 PM Chocolate Touch DCBs (From TriReme Medical): How Do They Work, Advantages And Updated Clinical Results
  Presenter(s):Andrew Holden, MBChB  
3:30 PM - 3:35 PM Value Of High-Pressure Non-Compliant Balloons For BTK Arterial Lesion Treatment: Why They Work Better And Other Technical Tips
  Presenter(s):Steven Kum, MD  
3:36 PM - 3:41 PM Update On The TANGO Trial Using The Bullfrog Balloon Device (Mercator Medical Systems) To Inject Sirolimus Drug Into Lesion Wall Before Angioplasty: How Does It Work And Results
  Presenter(s):Ehrin Armstrong, MD  
3:42 PM - 3:47 PM Value Of The Passeo-18Lux DCB For Treating BTK Lesions With Or Without Bare Metal Stents
  Presenter(s):Gunnar Tepe, MD  
3:48 PM - 3:53 PM Unfavorable Balloon Wrap (Candy) Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided: The Chocolate DCB Is One Way
  Presenter(s):Jos C. van den Berg, MD, PhD  
3:54 PM - 3:59 PM The Importance Of Dissection In Angioplasty Treatment Of BTK Lesions: How To Prevent And Treat Such Dissections: The Value Of Tacks (From Intact Vascular): How Do They Work
  Presenter(s):Andrew Holden, MBChB  
4:00 PM - 4:05 PM 24-Month Results Of TOBA II BTK Trial Of The Tack Device To Decrease Dissections With Balloon Angioplasty Of BTK Lesions Show Safety And 94.7% Target Limb Salvage
  Presenter(s):Patrick J. Geraghty, MD  
4:06 PM - 4:12 PM Panel Discussion
END OF SESSION 61
 
SESSION 62 SCHEDULE
Thursday
SESSION 62: NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
x
4:12 PM - 4:17 PM Prophylactic Endoanchors (Medtronic) With TEVAR For Complex Anatomy Improves Outcomes: Technical Tips For Their Use In TEVAR
  Presenter(s):Jean M. Panneton, MD  
4:18 PM - 4:23 PM New Developments From The ANCHOR Registry With Over 5 Years Of Follow-Up Show The Value Of Endoanchors When Used Prophylactically For Certain Indications Prevent Endoleaks And Migration: What Are Those Indications
  Presenter(s):William D. Jordan Jr., MD  
4:24 PM - 4:29 PM New Developments From The ANCHOR Registry With >5 Years Follow-Up Show That Endoanchors Can Be Used To Treat Endoleaks And Migration Effectively In Hostile Neck Anatomy: The Proof
  Presenter(s):Jean-Paul de Vries, MD, PhD  
4:30 PM - 4:35 PM Vesteck – The Next Generation Of Endoanchor Technology: How Does It Work And Where Does It Stand
  Presenter(s):David H. Deaton, MD, FACS  
4:36 PM - 4:41 PM Balloon Optimized Molding For Better Deployment And Sealing Of Ovation Alto Low Profile Endografts For EVAR: How To Do It And How It Helps Prevent Endoleaks And Migration
  Presenter(s):David J. Minion, MD  
4:42 PM - 4:48 PM Panel Discussion
END OF SESSION 62
 
SESSION 63 SCHEDULE
Thursday
SESSION 63: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
Moderators:James F. Benenati, MD / TBD  
x
CLOT REMOVING DEVICES
4:48 PM - 4:53 PM Percutaneous Embolectomy Or Thrombectomy With The Indigo System (From Penumbra): What Makes It Different, Technical Tips, Results And Limitations
  Presenter(s):David J. Dexter, MD  
4:54 PM - 4:59 PM Newer Pharmaco-Mechanical Endovascular Clot Removal Systems: When And Why Is Each Device Best To Use
  Presenter(s):Guillermo A. Escobar, MD  
5:00 PM - 5:05 PM Catheter Based Vacuum Assisted Thrombectomy For Acute Limb Ischemia: How Does It Work: Advantages And Limitations: From A Multicenter Study: Key Findings From The INDIAN Trial
  Presenter(s):Carlo Setacci, MD / Gianmarco de Donato, MD  
VASCULAR OCCLUSIVE DEVICES
5:06 PM - 5:11 PM Technical Tips For Effective Coil Embolization: Importance Of Dense Packing; Coils With Fibers Versus Plain Metal Coils; Value And Indications For Different Coils
  Presenter(s):James F. Benenati, MD / Constantino Pena, MD  
5:12 PM - 5:17 PM Why Ruby Coils, The Penumbra Occlusion Device (POD) And Packing Coils Have Different Uses And Why They Are Valuable And Cost Effective For Different Lesions: Technical Tips For Optimizing
  Presenter(s):Sean P. Lyden, MD  
5:18 PM - 5:23 PM Caterpillar™ Embolic Plug (From Bard): How Does It Work: Advantages And Clinical Results
  Presenter(s):Andrew Holden, MBChB  
5:24 PM - 5:29 PM How To Treat Type 1A Endoleaks With Ruby Coils: When Will They Work; When Will They Not: Technical Tips
  Presenter(s):Mazin Foteh, MD  
5:30 PM - 5:35 PM How To Insert Large Vessel Embolization Devices (PODs) Through Low Profile Access
  Presenter(s):Frank R. Arko, MD  
5:36 PM - 5:44 PM Panel Discussion
End of Program H

END OF SESSION 63
 
SESSION 64 SCHEDULE
Thursday
SESSION 64: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
x
7:00 AM - 7:04 AM Introduction To Veins At VEITH
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:05 AM - 7:10 AM AVF CEAP Revision 2020
  Presenter(s):Marc A. Passman, MD  
7:11 AM - 7:16 AM CEAP, VCSS, HASTI: Their Significance And How To Utilize
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
7:17 AM - 7:22 AM Physiology Of Venous Return
  Presenter(s):Brajesh K. Lal, MD  
7:23 AM - 7:28 AM What Are The Causes Of Symptoms In CEAP C Zero Class Of Patients: Implications For Therapy
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
7:29 AM - 7:34 AM How To Measure DUS Venous Reflux Volume: Is It More Important Than Reflux Time
  Presenter(s):Sergio Gianesini, MD, PhD, FACS  
7:35 AM - 7:40 AM Status Of The Evidence For C2 Intervention
  Presenter(s):Peter Gloviczki, MD  
7:41 AM - 7:46 AM An Algorithm To Predict Disease Severity In C2 Patients
  Presenter(s):Mikel Sadek, MD  
7:47 AM - 7:52 AM Evidence Summary On The Pathophysiology Of Varicose Veins
  Presenter(s):Thomas W. Wakefield, MD  
7:53 AM - 7:58 AM CVD: A Clinical Approach Algorithm
  Presenter(s):Seshadri Raju, MD  
7:59 AM - 8:04 AM Understanding Venous Physiology Helps Guide Therapy
  Presenter(s):Fedor Lurie, MD, PhD  
8:05 AM - 8:10 AM Non-Venous Causes Of The Swollen Extremity
 
8:11 AM - 8:16 AM Quality Of Life Tools Reflect Disease Severity, But They Can Be Improved
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
8:17 AM - 8:22 AM Panel Discussion
END OF SESSION 64
 
SESSION 65 SCHEDULE
Thursday
SESSION 65: VENOUS IMAGING AND BIOLOGY
x
8:23 AM - 8:28 AM Identifying Reflux Pathways With Duplex Ultrasound Mapping
  Presenter(s):Neil M. Khilnani, MD  
8:29 AM - 8:34 AM Are They Venous Ulcers
  Presenter(s):Raghu Kolluri, MD  
8:35 AM - 8:40 AM Venous Consensus Project Update
  Presenter(s):Lawrence V. Hofmann, MD  
8:41 AM - 8:46 AM Ambulatory Venous Pressure, Air Plethysmography, And The Role Of Calf Venous Pump In Chronic Venous Disease
  Presenter(s):Seshadri Raju, MD  
8:47 AM - 8:52 AM Role Of Foot Static Disorders In Chronic Venous Disease
  Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT  
8:53 AM - 8:58 AM Inflammation And CVD
  Presenter(s):Joseph D. Raffetto, MD  
8:59 AM - 9:04 AM Does Deep Venous Reflux Matter With Superficial Ablation
  Presenter(s):Peter Henke, MD  
9:05 AM - 9:10 AM Genetics Involving VV And VLU
  Presenter(s):Joseph D. Raffetto, MD  
9:11 AM - 9:16 AM A New Noninvasive Method To Measure Lower Limb Venous Outflow Resistance
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
9:17 AM - 9:22 AM Value Of Coordinated Registry Network: Information Obtained
  Presenter(s):Steve Elias, MD  
9:23 AM - 9:28 AM Panel Discussion
END OF SESSION 65
 
SESSION 66 SCHEDULE
Thursday
SESSION 66: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
9:29 AM - 9:34 AM Results Of Randomized Controlled Trial MOCA Versus Cyanoacrylate
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
9:35 AM - 9:40 AM “Choosing Wisely” Items For Chemical Or Thermal Ablation In The Treatment Of The Incompetent Saphenous Veins And Recurrence
  Presenter(s):Claudine M. Hamel-Desnos, MD  
9:41 AM - 9:46 AM Rethinking Endovenous Techniques To Define Cost-Effectiveness
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
9:47 AM - 9:52 AM Saphenous Sparing: Instructions For Users
  Presenter(s):Sergio Gianesini, MD, PhD, FACS  
9:53 AM - 9:58 AM Important Factors And Misconceptions In Skin End Organ Damage
  Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT  
9:59 AM - 10:04 AM What Drugs Do I Recommend For Symptomatic Venous Disease
  Presenter(s):Jorge H. Ulloa, MD, FACS  
10:05 AM - 10:10 AM Ablative Procedures And Cost Effectiveness
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
10:11 AM - 10:16 AM SVT Treatment During Pregnancy: Treatment Choices
  Presenter(s):Ellen D. Dillavou, MD  
10:17 AM - 10:22 AM Vein Histopathology: 5.5 Years After Cyanoacrylate Closure
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
10:23 AM - 10:28 AM Saphenous Ablation On Anticoagulation; Is It Safe, Effective And Durable
  Presenter(s):Glenn Jacobowitz, MD  
10:29 AM - 10:34 AM Panel Discussion
END OF SESSION 66
 
SESSION 67 SCHEDULE
Thursday
SESSION 67: THERMAL AND NON-THERMAL ABLATION
x
THERMAL AND NON-THERMAL ABLATION I
10:35 AM - 10:40 AM Decision Making In Saphenous Ablation: What To Use When
  Presenter(s):Ellen D. Dillavou, MD  
10:41 AM - 10:46 AM HIFU: Is It Ready For Prime Time
  Presenter(s):Mark S. Whiteley, MS, FRCS  
10:47 AM - 10:52 AM Tips, Tricks And Limitations: HIFU
  Presenter(s):Mark S. Whiteley, MS, FRCS  
10:53 AM - 10:58 AM Tips, Tricks And Limitations: Perforator Ablation
  Presenter(s):Steve Elias, MD  
10:59 AM - 11:04 AM Tips, Tricks And Limitations: Varithena
  Presenter(s):Edward G. Mackay, MD  
11:05 AM - 11:10 AM Tips, Tricks, And Limitations: Ultrasound Guided Foam Sclerotherapy
  Presenter(s):Jean Luc Gerard, MD  
11:11 AM - 11:16 AM Panel Discussion
THERMAL AND NON-THERMAL ABLATION II
Moderator(s): Alan M. Dietzek, MD, RPVI, FACS / Steve Elias, MD  
11:17 AM - 11:22 AM Tips, Tricks, And Limitations: Liquid Sclerotherapy
  Presenter(s):Victor M. Canata, MD, PhD  
11:23 AM - 11:28 AM Tips, Tricks And Limitations: Clarivein
  Presenter(s):Steve Elias, MD  
11:29 AM - 11:34 AM Tips, Tricks And Limitations: Laser Truncal Ablation
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
11:35 AM - 11:40 AM Tips, Tricks And Limitations: Radiofrequency Ablation
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
11:41 AM - 11:46 AM Tips, Tricks And Limitations: Brazilian Phlebectomy
  Presenter(s):Gutenberg A. Gurgel, MD, MSc  
11:47 AM - 11:52 AM Cutting-Catheter Assisted Foam Sclerotheraphy: Tips, Tricks And Limitations
  Presenter(s):Lorena Grillo, MD  
11:53 AM - 11:58 AM Tips, Tricks And Limitations: VenaSeal
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
11:59 AM - 12:04 PM Safety And Efficacy Of Endovenous Ablations In Octogenarians, Nonagenarians, And Centenarians
  Presenter(s):Enrico Ascher, MD  
12:05 PM - 12:10 PM SVT Management In 2020: Anything New
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
12:11 PM - 12:16 PM Panel Discussion
12:16 PM - 12:45 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 67
 
SESSION 68 SCHEDULE
Thursday
SESSION 68: SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, EXOTIC VEIN TREATMENT
x
12:45 PM - 12:50 PM Foam Therapies (PCF Versus PEM): When To Use And Does It Make A Difference
  Presenter(s):Edward G. Mackay, MD  
12:51 PM - 12:56 PM Patient Preferences For Thermal Ablation Versus Non-Thermal, Non-Tumescent Varicose Vein Treatments: A Choice-Based Conjoint (CBS) Analysis
  Presenter(s):Peter J. Pappas, MD  
12:57 PM - 1:02 PM Randomized Controlled Study Of EVLA And Foam In The SSV-Fovelass Study: 3-Year Results
  Presenter(s):Claudine M. Hamel-Desnos, MD  
1:03 PM - 1:08 PM CLACS In Paraguay Results Of The Aesthetic Phlebology Trial
  Presenter(s):Victor M. Canata, MD, PhD  
1:09 PM - 1:14 PM Superficial Ablation Outcomes (5 Years) In 13,000 Patients
  Presenter(s):Peter J. Pappas, MD  
1:15 PM - 1:20 PM Labial Varices: Choices And How I Do It
  Presenter(s):Ellen D. Dillavou, MD  
1:21 PM - 1:26 PM Which Saphenous Vein Recanalization Should Be Treated
  Presenter(s):Kathleen D. Gibson, MD  
1:27 PM - 1:32 PM Is Combination Therapy Laser And Sclerotherapy More Efficacious For Telangiectatic Treatment
  Presenter(s):Gutenberg A. Gurgel, MD, MSc  
1:33 PM - 1:38 PM Concomitant Versus Staged Tributary Treatment
  Presenter(s):Kathleen D. Gibson, MD  
1:39 PM - 1:44 PM Panel Discussion
END OF SESSION 68
 
SESSION 69 SCHEDULE
Thursday
SESSION 69: VENOUS SOCIETAL AND GOVERNANCE
x
1:45 PM - 1:50 PM CMS And Commercial Policy Update On Non-Thermal Ablation
  Presenter(s):Harold J. Welch, MD  
1:51 PM - 1:56 PM The Future Of Venous Reimbursement In A Non-Fee For Service Environment
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
1:57 PM - 2:02 PM Can We Use The Data From VQI VVR To Advocate For Coverage Of Venous Procedures
  Presenter(s):Nicholas H. Osborne, MD, MS  
2:03 PM - 2:08 PM Who Should Fund The Management Of C2 Disease And Why
  Presenter(s):Sarah Onida, MD, PhD  
2:09 PM - 2:14 PM The Irony Of Overtreatment And Undertreatment In Venous Disease: What Can Be Done
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
2:15 PM - 2:20 PM Results Of Appropriateness Criteria (AVF) I
  Presenter(s):Kathleen J. Ozsvath, MD  
2:21 PM - 2:26 PM Results Of Appropriateness Criteria (AVF) II
  Presenter(s):Kathleen J. Ozsvath, MD  
2:27 PM - 2:32 PM Ground Zero On 9/11: What Did We Learn
  Presenter(s):Mark A. Adelman, MD  
2:33 PM - 2:38 PM Focused Practice Designation – Venous Disease Treatment
  Presenter(s):Brajesh K. Lal, MD  
2:39 PM - 2:44 PM Prior Authorization As A Utilization Management Tool For Elective Superficial Venous Procedures Is Worthless
  Presenter(s):Todd Berland, MD  
2:45 PM - 2:50 PM Panel Discussion
END OF SESSION 69
 
SESSION 70 SCHEDULE
Thursday
SESSION 70: MORE SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
2:51 PM - 2:56 PM From The AVF And SVS: EHIT Recommendations
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
2:57 PM - 3:02 PM Saphenous Incompetence With Post-Thrombotic Deep Veins
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
3:03 PM - 3:08 PM Which Factors Increase VTE Risk For Superficial Venous Procedures
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
3:09 PM - 3:14 PM Ablation Outcomes In Obese Patients
  Presenter(s):Peter J. Pappas, MD  
3:15 PM - 3:20 PM Varithena® VLU Registry: The Effects Of Polidocanol Endovenous Microfoam On Wound Healing And Recurrence
  Presenter(s):Raghu Kolluri, MD  
3:21 PM - 3:26 PM Varicose Veins Among Klippel Trenaunay Syndrome: What You Should Know About
  Presenter(s):Byung-Boong Lee, MD  
3:27 PM - 3:32 PM Radiofrequency Ablation Increases The Incidence Of Endothermal Heat Induced Thrombosis
  Presenter(s):Anil P. Hingorani, MD  
3:33 PM - 3:38 PM European College Of Phlebology Guideline for Truncal Ablation
  Presenter(s):Kursat A. Bozkurt, MD  
3:39 PM - 3:44 PM Risk Factors For EHIT And Recanalization: An Analysis Of 10,000 Patients
  Presenter(s):Anil P. Hingorani, MD  
3:45 PM - 3:55 PM Panel Discussion
END OF SESSION 70
 
SESSION 71 SCHEDULE
Thursday
SESSION 71: VENOUS CLINICAL TRIALS; LYMPHATIC AND VEIN TREATMENT STRATEGIES
x
3:56 PM - 4:01 PM Proprietary Compounded Microfoam: Meta-Analysis
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
4:02 PM - 4:07 PM What Venous Trials Do We Need
  Presenter(s):Mark H. Meissner, MD  
4:08 PM - 4:13 PM Unilateral, Bilateral, Staged Endovenous Ablation – VQI Data
  Presenter(s):Nicholas H. Osborne, MD, MS  
4:14 PM - 4:19 PM The Recalcitrant Ulcer: Our 52-Week Analysis
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
4:20 PM - 4:25 PM First Experience: Russian Glue “Cyanoacrylate”
  Presenter(s):Evgeny Shaydakov, MD, PhD  
4:26 PM - 4:31 PM VenaSeal Spectrum Study: RCT Study Overview
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
4:32 PM - 4:37 PM Treating Low And Moderate Severity Venous Disease Is Beneficial – Data From The VQI VVR
  Presenter(s):Nicholas H. Osborne, MD, MS  
4:38 PM - 4:43 PM A Newer Laser Fiber: All Fibers Are Not The Same
  Presenter(s):Evgeny Shaydakov, MD, PhD  
4:44 PM - 4:49 PM What Articles Are JVS-VL Looking For And How Can You Write A Paper That Will Be Accepted And Published
  Presenter(s):Peter Gloviczki, MD  
4:50 PM - 4:55 PM Panel Discussion
LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA
Moderator(s): Joseph A. Caprini, MD / Thomas F. O'Donnell, Jr., MD  
4:56 PM - 5:01 PM Diagnosis Of Lipedema And Treatment
  Presenter(s):Steven M. Dean, DO  
5:02 PM - 5:07 PM Overview Of Lymphatic Anatomy, Physiology And Imaging Techniques
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
5:08 PM - 5:13 PM Clinical Characteristics Of Lower Extremity Lymphedema
  Presenter(s):Steven M. Dean, DO  
5:14 PM - 5:19 PM Evidence Based Compression Recommendations For Lymphedema
  Presenter(s):Joseph A. Caprini, MD  
5:20 PM - 5:25 PM Venolymphatic Edema And Its Treatment Options
  Presenter(s):Raghu Kolluri, MD  
5:26 PM - 5:31 PM Phlebolymphedema: Hallmark Of Combined Insufficiency Of Venous-Lymphatic System
  Presenter(s):Byung-Boong Lee, MD  
5:32 PM - 5:37 PM Correlation Amongst Transabdominal/Transvaginal Duplex Versus Venography For Pelvic Venous Insufficiency And Leg Varicosities
  Presenter(s):Lourdes Reina, MD  
5:38 PM - 5:43 PM Advanced Pneumatic Compression: Continued Improvement In Quality Of Life
  Presenter(s):Thomas S. Maldonado, MD  
5:44 PM - 5:49 PM Panel Discussion
EXAMINING THE EVIDENCE
Moderator(s): Jean Luc Gerard, MD / Lorena Grillo, MD  
5:50 PM - 5:55 PM Bone Perforator: What Is The Significance
  Presenter(s):Jean Luc Gerard, MD  
5:56 PM - 6:01 PM Is Saphenous Vein Stripping A Cost-Effective Treatment
  Presenter(s):Lourdes Reina, MD  
6:02 PM - 6:07 PM Ablative Risks Prior And After Flying: What Do You Tell Your Patients
  Presenter(s):Sarah Onida, MD, PhD  
6:08 PM - 6:13 PM 1470mm Laser And Wound Care Trial
  Presenter(s):Lorena Grillo, MD  
6:14 PM - 6:20 PM Panel Discussion
End of Program I

END OF SESSION 71
 
SESSION 72 SCHEDULE
Thursday
SESSION 72: STROKE 2021 INCLUDING COVID
x
7:45 AM - 7:50 AM Introduction
  Presenter(s):Allan L. Brook, MD  
7:51 AM - 8:01 AM Lessons Learned On Patient Selection For Acute Stroke Treatment
  Presenter(s):Michael D. Hill, MD  
8:02 AM - 8:12 AM Innovative And Novel Stroke Therapies That Are In The Pipeline
  Presenter(s):Michael D. Hill, MD  
8:13 AM - 8:23 AM COVID-19 Overview Of What Happened
  Presenter(s):Seon-Kyu Lee, MD, PhD  
8:24 AM - 8:34 AM Long -Term Effects Of Stroke: COVID-19 Is Here To Stay
  Presenter(s):Reade A. De Leacy, MBBS  
8:35 AM - 8:45 AM How CSC/Organized Medicine Helped Prepare Us For The COVID Onslaught
  Presenter(s):Ansaar T. Rai, MD  
8:45 AM - 8:50 AM Collateral Physiologic Flow: Our Friends And Our Foes
  Presenter(s):Allan L. Brook, MD  
8:50 AM - 9:00 AM Panel Discussion
9:00 AM - 9:10 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 72
 
SESSION 73 SCHEDULE
Thursday
SESSION 73: CAROTIDS AND REVASCULARIZATION
x
9:11 AM - 9:21 AM Carotid Revascularization: Observations Of Change Over The Course Of A Career
 
9:22 AM - 9:33 AM Medical Management Of Carotid Disease
  Presenter(s):Michael D. Hill, MD  
9:33 AM - 9:43 AM TCAR: Technical Pearls: Why It’s The Latest Trending Vascular Procedure
  Presenter(s):Mahmoud B. Malas, MD, MHS  
9:44 AM - 9:54 AM TCAR: Why Not Just Do An Endarterectomy
  Presenter(s):Marc L. Schermerhorn, MD  
9:55 AM - 10:05 AM Pooled Analysis With Greater Power From The CREST And ACT I Trials With Asymptomatic Patients Clarifies The CREST Conclusion: Sex Makes No Difference Between CEA And CAS While Oldest Age Group Demonstrates Worse Results With CAS
 
10:06 AM - 10:30 AM Panel Discussion
10:30 AM - 10:40 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 73
 
SESSION 74 SCHEDULE
Thursday
SESSION 74: INTRACRANIAL HEMORRHAGE
x
10:40 AM - 10:50 AM Hemicraniectomy: Why It Is Not A Lost Art, And Benefits
  Presenter(s):Adam S. Arthur, MD  
10:51 AM - 11:01 AM Devices Are The Next Generation Of Aneurysm Treatment Or Is It Prevention
  Presenter(s):Ajay K. Wakhloo, MD, PhD, FAHA  
11:02 AM - 11:12 AM Intrasaccular Devices: Overview And Indications
  Presenter(s):David J. Altschul, MD  
11:13 AM - 11:23 AM Unruptured Aneurysms: Why Do We Treat These
  Presenter(s):James Milburn, MD  
11:24 AM - 11:34 AM Intracranial Hemorrhage: Open Or Closed Treatment-Decision Tree
  Presenter(s):Brian L. Hoh, MD  
11:35 AM - 11:45 AM Sub-Dural Hemorrhage Endovascular Therapy: Trials And Tribulations
  Presenter(s):Adam S. Arthur, MD  
11:46 AM - 11:56 AM Cerebrovascular Vascular Malformation Classification And Management Decisions
  Presenter(s):Wayne F. Yakes, MD  
11:56 AM - 12:10 PM Panel Discussion
End Of Program J

12:10 PM - 1:00 PM Lunch – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 74
 
SESSION 79 SCHEDULE
Friday
SESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
x
6:40 AM - 6:45 AM A Multidisciplinary Approach To Prevent SCI During Endovascular TAAA Repairs
  Presenter(s):Patrick W. Kelly, MD  
6:46 AM - 6:51 AM Strategies To Minimize Paraplegia After TAAA Repairs: How A Biomarker Can Help
  Presenter(s):Bijan Modarai, PhD, FRCS / Adam Beck, MD  
6:52 AM - 6:57 AM New Developments In Preventing SCI With Endo And Open TAAA Repairs
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
6:58 AM - 7:03 AM Update On The Value Of Motor Evoked Potentials To Decrease SCI With TAAA Repairs: What Is The Difference Between Peripheral And Central SCI
  Presenter(s):Geert Willem H. Schurink, MD, PhD / Barend M.E. Mees, MD, PhD, FEBVS / Michael J. Jacobs, MD  
7:04 AM - 7:09 AM Cerebrospinal Fluid (CSF) Drainage (To Decrease SCI) Is Not A Benign Procedure: Why: When Not And When To Use It
  Presenter(s):Gustavo S. Oderich, MD, FACS  
7:10 AM - 7:15 AM SCI Is More Severe And Resolves Less When Routine CSF Drainage Is Used With TAAA Repairs: When Should It Be Used Selectively And With What Precautions
  Presenter(s):Adam Beck, MD  
7:16 AM - 7:21 AM Status Of CSF Drainage With TAAA Repairs In Europe: Evidence Is Lacking: What Is The Standard Practice
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
7:22 AM - 7:27 AM Near Infrared Spectrometry (NIRS) Monitoring Is Helpful In Decreasing SCI With TAAA Repairs: How To Do It: Why Is There Controversy
  Presenter(s):Carlos H. Timaran, MD  
7:28 AM - 7:33 AM The Intraspinal Collateral Arterial Network And Its Importance In Preventing SCI And Paraplegia With Complex Aortic Repairs
  Presenter(s):Martin Czerny, MD  
7:34 AM - 7:39 AM Current Strategies To Minimize SCI With TAAA Repairs, Endo And Open: Status Of Intercostal Embolization As Preconditioning To Prevent Ischemia (MIS2ACE): Status Of PAPA-ARTIS RCT
  Presenter(s):Christian D. Etz, MD, PhD  
7:40 AM - 7:45 AM Clinical Experience With Intercostal Coil Embolization (MIS2ACE) To Prevent SCI With Endovascular TAAA Repair
  Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD / Christian D. Etz, MD, PhD  
7:46 AM - 7:53 AM Panel Discussion
END OF SESSION 79
 
SESSION 80 SCHEDULE
Friday
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR)
x
MESH COVERED STENTS
7:53 AM - 7:58 AM Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter
  Presenter(s):Max Amor, MD  
7:59 AM - 8:04 AM Advantages And Limitations Of Mesh Covered Stents In CAS: Are They Really Better
  Presenter(s):Laura Capoccia, MD, PhD  
8:05 AM - 8:10 AM 7-Year Experience With Micromesh Stents For CAS: Are There Downsides (Thrombosis Or ISR): Technical Tips To Optimize Their Results
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
8:11 AM - 8:16 AM New Multicenter Data Showing The Long-Term Value Of The C-Guard Micronet Mesh Covered Stent For CAS In High Risk Carotid Lesions (Thrombotic, Calcified And Symptomatic) From The Flow-Guard And Other Trials
 
TCAR RELATED TOPICS
8:17 AM - 8:22 AM TCAR Versus CEA (Carotid Endarterectomy): A Propensity Matched SVS VQI Study: 1-Year Results Show Equal Stroke/Death Rates And Decreased Cranial Nerve Injuries With TCAR: Findings Also Confirmed By A Meta-Analysis
  Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD  
8:23 AM - 8:28 AM TCAR Versus Transfemoral CAS (TFCAS): A Propensity Matched SVS VQI Study Shows That TCAR Has Lower Stroke And Death Rates Than TFCAS
  Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS / Vikram S. Kashyap, MD  
8:29 AM - 8:34 AM Why I Am Uncertain That TCAR Will Have Better Outcomes Than TFCAS: What Does The CREST 2 Registry Show
  Presenter(s):Thomas G. Brott, MD / William A. Gray, MD / Giancarlo Biamino, MD, PhD  
8:35 AM - 8:40 AM DEBATE: For TFCAS Reversal Or Cessation Of Flow With The Gore Or MoMA Device Cerebral Embolic Protection Is No Better Than Filter Protection: Why Is This So
  Presenter(s):Marc L. Schermerhorn, MD  
8:41 AM - 8:46 AM DEBATE: Not So: In Some Specific Circumstances Reversal Or Cessation Of Flow Protection During TFCAS Is Better And Safer Than Filter Protection
  Presenter(s):Giancarlo Biamino, MD, PhD / William A. Gray, MD  
8:47 AM - 8:52 AM Based On Data To Date When Should TCAR Replace CEA And When Should It Not: A Balanced View
  Presenter(s):Vikram S. Kashyap, MD  
8:53 AM - 8:58 AM TCAR Seems Better Than TFCAS And Equal To CEA: It Has A Bright Future: What Are Its Drawbacks
  Presenter(s):Wesley S. Moore, MD  
8:59 AM - 9:07 AM Panel
9:07 AM - 9:17 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 80
 
SESSION 81 SCHEDULE
Friday
SESSION 81: MORE CAROTID HOT TOPICS RELATED TO TCAR, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS AND COGNITIVE FUNCTION
x
9:17 AM - 9:22 AM TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why It Should Be The Procedure Of Choice In Those Conditions
  Presenter(s):Peter A. Schneider, MD  
9:23 AM - 9:28 AM DEBATE: TCAR Is Not Hard To Learn: Results Are Unrelated To Operator Experience In ROADSTER 2 Trial
  Presenter(s):Vikram S. Kashyap, MD  
9:29 AM - 9:34 AM DEBATE: Not So: TCAR Has A Steeper Learning Curve Than Commonly Thought: Some Precautions To Prevent Adverse Events
  Presenter(s):Michael B. Silva, Jr., MD / Charles Thang, MD  
9:35 AM - 9:40 AM Learning And Optimizing The TCAR Procedure
  Presenter(s):Edward Y. Woo, MD / Steven D. Abramowitz, MD  
9:41 AM - 9:46 AM Complications Of TCAR: How To Avoid Them And Fix Those That Occur
  Presenter(s):Thomas S. Maldonado, MD  
9:47 AM - 9:52 AM Adjunctive EEG Can Help With TCAR And Decrease The Stroke Rate: When And How
  Presenter(s):Todd R. Vogel, MD, MPH  
9:53 AM - 9:58 AM Mini-Incision CEA Is Better And Less Costly Than TCAR
  Presenter(s):Enrico Ascher, MD  
9:59 AM - 10:04 AM TCAR Can Be Performed Under Local Anesthesia With Outcomes Equal To TCAR Under General Anesthesia: From A VQI Study: How To Do It Safely
  Presenter(s):Dipankar Mukherjee, MD  
SIGNIFICANCE OF SMALL DW MRI DEFECTS AFTER CEA/CAS
10:05 AM - 10:10 AM DEBATE: How Size And Number Of Silent Brain Infarcts (DW MRI Defects) After CEA/CAS Affect Cognitive Changes: They Really Do Matter
  Presenter(s):Wei Zhou, MD  
10:11 AM - 10:16 AM DEBATE: Silent DWI MRI Brain Lesions (Small Infarcts) After CEA/CAS Don’t Matter
  Presenter(s):Thomas G. Brott, MD  
10:17 AM - 10:22 AM Why Asymptomatic Carotid Stenosis (ACS) Is Associated With Impaired Cognitive Function And Silent Infarcts: However, CEA And CAS For ACS Cause More Cognitive Impairment Than They Prevent
  Presenter(s):J. David Spence, MD  
10:23 AM - 10:30 AM Panel Discussion
END OF SESSION 81
 
SESSION 82 SCHEDULE
Friday
SESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
x
10:30 AM - 10:35 AM Comparative Cost Effectiveness: TCAR Versus CEA Versus TFCAS
  Presenter(s):Mohammad H. Eslami, MD, MPH  
10:36 AM - 10:41 AM Transcranial Doppler (TCD) Hits During TCAR: When Do They Occur And What Is Their Significance
  Presenter(s):Cynthia K. Shortell, MD  
10:42 AM - 10:47 AM Value Of Lithotripsy (Shockwave) For CAS In Heavily Calcified Lesions: How To Do It Safely And Technical Tips: Limitations And Precautions
  Presenter(s):Max Amor, MD  
10:48 AM - 10:53 AM Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications
  Presenter(s):Francesco Speziale, MD / Wassim Mansour, MD / Pasqualino Sirignano, MD / Carlo Setacci, MD  
10:54 AM - 10:59 AM OCT Proves CAS Is Rendered Safer Because Emboli Are Decreased By Mesh Covered Stents: The Evidence
  Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD  
11:00 AM - 11:05 AM TCAR Versus Minimal Incision CEA: Cost Effectiveness, Advantages And Limitations Of Both
  Presenter(s):Robert M. Proczka, MD, PhD  
11:06 AM - 11:12 AM Panel Discussion
TIMING OF CAROTID INTERVENTIONS AFTER SYMPTOM ONSET
11:12 AM - 11:17 AM Optimal Timing Of Carotid Revascularization (CEA, TFCAS, TCAR) After Symptom Onset: Within 48 Hours Risk Is Increased For All Procedures; After 48 Hours Risk Is Less With CEA And TCAR Than With TFCAS: Based On Large National Database Study
  Presenter(s):Mahmoud B. Malas, MD, MHS  
11:18 AM - 11:23 AM DEBATE: It’s Reasonable To Perform CEA Within 48 Hours After A Stroke’s Symptoms Start: Under What Conditions And What Precautions Should Be Taken
  Presenter(s):R. Clement Darling III, MD  
11:24 AM - 11:29 AM DEBATE: Patients With Moderate To Severe Strokes Do Poorly With Both CEA And CAS Done Within 48 Hours Of Symptom Onset: Both Procedures Should Be Avoided During This Period: How Long Should One Wait
  Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS  
11:30 AM - 11:35 AM When Is CEA Within 48 Hours Of Stroke Symptom Onset Necessary: What Are The Risks: How To Make It Reasonably Safe: When Is It Totally Contraindicated
  Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS  
11:36 AM - 11:41 AM What Is The Best Medical Treatment For Patients With Carotid Stenosis (Symptomatic And Asymptomatic): Can High Risk Plaques Be Made Low Risk And Can They Be Made Smaller: Are Some Plaques Resistant To Medical Treatment And Why
  Presenter(s):J. David Spence, MD  
11:42 AM - 11:47 AM Technical Tips and Maneuvers To Make Treatment Of High Carotid Lesions Safe And Relatively Simple
  Presenter(s):Richard J. Powell, MD  
11:48 AM - 11:53 AM Getting Non-Compliant Carotid Patients To Comply With Best Medical Treatment By Showing Them Their Duplex Scans And Pictures Of Hemorrhagic And Ulcerated Plaques
  Presenter(s):J. David Spence, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 12:50 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 82
 
SESSION 83 SCHEDULE
Friday
SESSION 83: MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
x
UPDATE ON CAROTID RCTs
12:50 PM - 12:55 PM Update On ACST 2: CEA Versus CAS For ACS: What Is It Telling Us And When Will We Have All The Answers
  Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS  
12:55 PM - 1:00 PM Initial Results Of ACST 2 Trial
  Presenter(s):Alison Halliday, MS, FRCS  
1:00 PM - 1:05 PM Not So Fast! ACST 2 Has Flaws That Invalidate Its Conclusions: What Are They
  Presenter(s):J. David Spence, MD  
1:06 PM - 1:11 PM Update On SPACE 2: CEA Versus Best Medical Treatment (BMT); CAS Versus BMT For ACS: Updated And Interesting Findings From A Stopped RCT
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
1:12 PM - 1:17 PM Update On CREST 2: CEA Versus BMT And CAS Versus BMT For ACS: Findings To Date And When Will We Have Final Results
  Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD  
1:18 PM - 1:23 PM Why Is BMT With Clopidogrel Different In The Arms Of CREST And CREST 2 And Why This Difference Could Invalidate The RCTs Results (Power Point Presentation With Synched Audio)
  Presenter(s):Timothy M. Sullivan, MD  
TANDEM CAROTID LESIONS
1:24 PM - 1:30 PM DEBATE: Tandem Lesions At The Carotid Bifurcation Plus The Common Carotid Or Innominate Arteries: Stroke And Mortality Risks Are Higher Than For Simple Bifurcation Lesions: How Best To Treat: Endo, Open, Staged, Hybrid
  Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc  
1:30 PM - 1:35 PM DEBATE: Tandem Carotid Lesions: Treatment Risks Need Not Be Increased: Based On A Meta-Analysis: How Best To Treat To Minimize Risk
  Presenter(s):Ross Naylor, MD, FRCS  
1:36 PM - 1:41 PM CEA And Retrograde Stenting Of A Tandem Proximal Lesion: Technical Tips To Make It Safe And Effective
  Presenter(s):Christopher J. Smolock, MD  
1:42 PM - 1:47 PM Optimal Management Of Extracranial Carotid Aneurysms In 2021: When Open; When Endo: Technical Tips And Results
  Presenter(s):Samuel R. Money, MD, MBA  
1:48 PM - 1:53 PM How Best To Treat Strokes Apparent During Or Right After CEA, CAS Or TCAR: Best Diagnostic Modalities And Treatments: What Skills Are Needed
  Presenter(s):Gert J. de Borst, MD, PhD  
1:54 PM - 2:02 PM Panel Discussion
END OF SESSION 83
 
SESSION 84 SCHEDULE
Friday
SESSION 84: MORE HOT CAROTID TOPICS: TREATMENT IN 2021 OF STRING SIGN, BIG CAROTID BODY TUMORS, AND CAROTID DISSECTIONS; OPTIMAL PLATELET AND PROTAMINE STRATEGIES; BENIGNANCY OF ACS; VALUE OF LOCAL ANESTHESIA; STROKE RISK WITH ACS PLAQUES - A WAY TO PREDICT HIGH RISK PLAQUES
x
2:02 PM - 2:07 PM Current Optimal Treatment For Carotid Artery Dissections: When Medical Treatment (Anticoagulation And BP Control); When Open Surgery; When Stenting With Proximal Protection: Precautions
  Presenter(s):Felice Pecoraro, MD  
2:08 PM - 2:13 PM How Best To Diagnose And Treat Near Occlusion Of The Internal Carotid Artery (ICA) In 2021: Based On A Meta-Analysis: Is This The ICA String Sign Of Past Descriptions
  Presenter(s):Gert J. de Borst, MD, PhD  
2:14 PM - 2:19 PM Technical Tips For Treating Large Shamblin III Carotid Body Tumors Safely; From An Ecuadorian Team Which Treats Many
  Presenter(s):Oscar L. Ojeda, MD, FACS  
2:20 PM - 2:25 PM Optimal Anti-Platelet Strategy Before And After CEA
  Presenter(s):Ross Naylor, MD, FRCS  
2:26 PM - 2:31 PM Value Of Protamine Use During CEA: How Should It Be Used And With What Precautions
  Presenter(s):David H. Stone, MD  
2:32 PM - 2:38 PM Panel Discussion
2:38 PM - 2:43 PM Restenosis After CEA And CAS Is Benign And Should Rarely Be Treated: When Can It Cause Strokes Justifying Prophylactic Treatment
  Presenter(s):Ross Naylor, MD, FRCS  
2:44 PM - 2:49 PM DEBATE: Local Anesthesia And Intraoperative Control With Duplex Or Angiography Is Key To Safe CEA: How To Do Them
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
2:50 PM - 2:55 PM DEBATE: Not So: CEA Can Be Performed Safely And Optimally Under General Anesthesia And Without Completion Duplex Or Angio Control: What Is Required To Do So And Are There Downsides To Duplex Or Angio Controls
  Presenter(s):Ali F. AbuRahma, MD  
2:56 PM - 3:01 PM Are Symptomatic And Asymptomatic Carotid Stenosis Really 2 Different Diseases As Some Suggest
  Presenter(s):Thomas G. Brott, MD  
3:02 PM - 3:07 PM What Percent Of Carotid Plaques Are Really High Stroke Risk: How To Detect Them With Ultrasound To See Neovascularization: Can High Risk Plaques Be Made Low Risk By Lipid Lowering
  Presenter(s):Henrik Sillesen, MD, DMSc  
3:08 PM - 3:13 PM When An Asymptomatic Carotid Stenosis (ACS) Patient Has A Stroke What Is Its Magnitude: Does It Make The Case For More Or Less Prophylactic CEAs And CASs
  Presenter(s):Gianluca Faggioli, MD  
3:14 PM - 3:20 PM Panel Discussion
3:20 PM - 3:30 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 84
 
SESSION 85 SCHEDULE
Friday
SESSION 85: MORE HOT AND CONTROVERSIAL CAROTID TOPICS AND NEW OR UPDATED CONCEPTS FOR ENDOVASCULAR TREATMENTS
x
HOT CAROTID TOPICS
3:30 PM - 3:35 PM Risks And Causes Of Non-Ipsilateral Stroke Complicating CEA
  Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc  
3:36 PM - 3:41 PM Unnecessary Redundant Testing/Imaging Prior To CEA: What Is The Reason For This Needless Addition To Health Care Costs
  Presenter(s):Reese A. Wain, MD  
3:42 PM - 3:47 PM Floating Clot At The Carotid Bifurcation Is A Prime Indication For Flow Reversal Technology During Treatment Of Carotid Stenosis: How Can Flow Reversal Best Be Achieved In This Setting
  Presenter(s):Juan C. Parodi, MD  
3:48 PM - 3:53 PM What Is Carotid Near Occlusion And How Is It Best Treated Currently: Conservatively, CEA, CAS
  Presenter(s):Weiguo Fu, MD  
3:54 PM - 3:59 PM DEBATE: CAS Is The Best Treatment For Young Patients With A High Grade Asymptomatic Carotid Stenosis (ACS)
  Presenter(s):Giancarlo Biamino, MD, PhD  
4:00 PM - 4:05 PM DEBATE: Not So: Young Patients With A High Grade ACS Should Not Be Treated By CAS Or CEA
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
4:06 PM - 4:12 PM Panel Discussion
NEW OR UPDATED CONCEPTS OR ENDO TREATMENTS
4:12 PM - 4:17 PM Clinical Judgment Is Required In The Application Of Evidence Based Medicine: RCTs Can Have Flaws Leading To Misleading Conclusions
  Presenter(s):J. David Spence, MD  
4:18 PM - 4:23 PM How Should Left Subclavian Artery Stenosis Be Treated In Patients Before Coronary Artery Bypass: Stent Versus Carotid Subclavian Bypass Versus Ignore But Don’t Use The Left Internal Mammary Artery
  Presenter(s):Jennifer L. Perri, MD, MBA  
4:24 PM - 4:29 PM Progress In Open And Endovascular Treatment For Erectile Dysfunction: Diagnosis And Treatment Of Cavernous Leak And Other Pathology: A New Horizon
  Presenter(s):Eric Allaire, MD, PhD  
4:30 PM - 4:35 PM Embolic Treatment Of Hemorrhoids: How To Do It And How Well Does It Work
  Presenter(s):Gloria Salazar, MD  
4:36 PM - 4:41 PM Transfemoral Transcaval Liver Biopsy: A Better Way And How To Do It
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
4:42 PM - 4:48 PM Panel Discussion
END OF SESSION 85
 
SESSION 86 SCHEDULE
Friday
SESSION 86: NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE, ENDOVASCULAR SUTURING AND WOUND CARE
x
4:48 PM - 4:53 PM Update On Large Bore Percutaneous Access Closure Devices: Key New Devices And Developments: How To Prevent Failure And Complications
  Presenter(s):Zvonimir Krajcer, MD, FACC  
4:54 PM - 4:59 PM Endovascular Suturing Devices At The Tip Of An 8-9 French Catheter To Close Large Bore Sheath Access From Inside: The NovelRad Device: How Does It Work And Present Status
  Presenter(s):Elchanan Bruckheimer, MBBS  
5:00 PM - 5:05 PM Access Complications Despite Modern Closure Devices And Endovascular Suturing: Strategies And Wound Care
  Presenter(s):Martin Storck, MD, PhD / Peter Reimer, MD, PhD  
PROGRESS IN WOUND CARE
5:06 PM - 5:11 PM Best Treatment Strategies For Complex Infected Groin Wounds After Vascular Surgery: When To Do What: Wide Debridement, Antibiotics, Muscle Flap Reconstruction Or Graft Removal
  Presenter(s):Jan-Willem Elshof, MD  
5:12 PM - 5:17 PM Optimal Treatment For Groin Infection After Prosthetic Bypasses From The Common Femoral Artery: How To Save The Graft And The Leg
  Presenter(s):Hosam F. El Sayed, MD  
5:18 PM - 5:23 PM New Developments In The Treatment Of Mixed Arterial And Venous Wounds And Ulcers
  Presenter(s):Katherine A. Gallagher, MD  
5:24 PM - 5:29 PM Value Of A Wound Care Center To A Vascular Practice: Who Should Staff It And How To Make It Revenue Positive
  Presenter(s):Venita Chandra, MD  
5:30 PM - 5:36 PM Panel Discussion
End of Program K

END OF SESSION 86
 
SESSION 87 SCHEDULE
Friday
SESSION 87: POPLITEAL DISEASE TOPICS RELATED TO NEW GUIDELINES, ANEURYSM TREATMENT (PRIMARY AND REDO), ENTRAPMENTS AND ATHERECTOMY FOR OCCLUSIVE LESIONS
x
POPLITEAL ANEURYSMS AND THEIR BEST CURRENT TREATMENTS
7:00 AM - 7:05 AM High Points Of New SVS Guidelines For The Treatment Of Popliteal Aneurysms: Roles Of Endo And Open Repairs
  Presenter(s):Patrick J. Geraghty, MD / Alik Farber, MD, MBA  
7:06 AM - 7:11 AM Contemporary Treatment Of Popliteal Aneurysms In 14 Countries: There Is Great Variation In Treatment, Techniques, Complications And Outcomes: The Take Home Message Is . . .
  Presenter(s):Martin Bjorck, MD, PhD  
7:12 AM - 7:17 AM DEBATE: Endovascular Repair Is The Best Option For Most Popliteal Aneurysms Requiring Repair: Recent Progress In The Procedure: When Is Open Repair Indicated
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
7:18 AM - 7:23 AM DEBATE: Open Repair With Prosthetic Bypass Graft Is Better Than Endovascular Treatment For Popliteal Aneurysms Requiring Repair
  Presenter(s):Laurent Chiche, MD, FEBVS  
7:24 AM - 7:29 AM Update On Optimal Treatment For Popliteal Aneurysms: When Observation; When Endo Repair; When Open Repair And How
  Presenter(s):Fred A. Weaver, MD, MMM  
7:30 AM - 7:36 AM Panel Discussion
7:36 AM - 7:41 AM What Are Complex Popliteal Aneurysms And How Should They Be Fixed: When Endo; When Open
  Presenter(s):Jacques Busquet, MD  
7:42 AM - 7:47 AM Rescue Procedures For Failed Endovascular Repairs Of Popliteal Aneurysms: Observation May Be Enough: If Not, Hybrid Versus Open Repair: Technical Tips
  Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS, FESC, FEBVS  
POPLITEAL ENTRAPMENTS
7:48 AM - 7:53 AM What’s New In The Treatment Of Popliteal Entrapments
  Presenter(s):Niten Singh, MD  
POPLITEAL ARTERY INJURY
7:54 AM - 7:59 AM Surgical Approach And Graft Usage For Popliteal Artery Injury From Posterior Knee Dislocation
  Presenter(s):Charles J. Fox, MD, FACS  
POPLITEAL ARTERY ATHERECTOMY
8:00 AM - 8:05 AM Value Of Orbital Atherectomy For Popliteal Artery Occlusive Lesions: Indications, Results, Precaution
  Presenter(s):Konstantinos P. Donas, MD  
8:06 AM - 8:12 AM Panel Discussion
END OF SESSION 87
 
SESSION 88 SCHEDULE
Friday
SESSION 88: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
x
8:12 AM - 8:17 AM Update On Deep Vein Use For Arterial Procedures: The NAIS Operation For Infections: Recent Technical Improvements
  Presenter(s):Patrick A. Stone, MD  
TREATMENT OF MYCOTIC ANEURYSMS
8:18 AM - 8:23 AM Optimal Treatment Of Mycotic AAAs In 2020: Value Of And Precautions With EVAR: Is It Ever A Stand-Alone Treatment
  Presenter(s):Timur P. Sarac, MD  
8:24 AM - 8:29 AM Rifampin Soaked Endografts To Treat Mycotic AAAs: How To Prepare Them And When To Use Them: Are They Stand-Alone Treatment Or Do They Need Adjunctive Techniques
  Presenter(s):Guillermo A. Escobar, MD  
8:30 AM - 8:35 AM Why Open Repair Is The Best Treatment For Mycotic AAAs: Is EVAR Ever Of Value
  Presenter(s):Yamume Tshomba, MD  
8:36 AM - 8:41 AM Best Treatment For Mycotic Aortic Aneurysms In The Thorax And Abdomen Based On Long-Term Results
  Presenter(s):Samy S. Nitecki, MD  
8:42 AM - 8:48 AM Panel Discussion
TREATMENT OF AORTIC AND ARTERIAL GRAFT AND ENDOGRAFT INFECTIONS
8:48 AM - 8:53 AM Infected Endografts After EVAR: Etiological Factors, Diagnosis, Treatment, Outcomes
  Presenter(s):Mohammad H. Eslami, MD, MPH  
8:54 AM - 8:59 AM Optimal Techniques For Treating Aorto-Iliac Graft And Endograft Infections In 2021
  Presenter(s):Anders Wanhainen, MD, PhD  
9:00 AM - 9:05 AM STABILISE Registry: Protocol And Update On Patients Recruitment
  Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD  
9:06 AM - 9:11 AM Update On Progress In The Optimal Treatment Of Aortic And Arterial Graft Infections: What’s New In 2021
  Presenter(s):Jean-Paul de Vries, MD, PhD  
9:12 AM - 9:17 AM DEBATE: Semi-Conservative Therapy May Be Best For Some Aortic Graft Infections: What Is It And When Will Saving All Or Part Of An Infected Graft Work
  Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG  
9:18 AM - 9:23 AM DEBATE: Not So: Aggressive Graft Removal Is Always Necessary In Treating Infections Involving Aortic Grafts
  Presenter(s):Franco Grego, MD  
9:24 AM - 9:29 AM Open Repair Of Suprarenal Aortic Graft Infections: Technical Tips And Long-Term Results
  Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS  
9:30 AM - 9:37 AM Panel Discussion
9:37 AM - 9:52 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 88
 
SESSION 89 SCHEDULE
Friday
SESSION 89: PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
x
VASCULAR HOLOGRAPHY
9:52 AM - 9:57 AM How Will The Microsoft Hololens Look Through Patients’ Bodies And Facilitate Endovascular Interventions: The ARCUS System Of Augmented Reality And Its Value In Vascular Surgery
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
9:58 AM - 10:03 AM Real View Holographic Imaging: How Will It Help In Endovascular Treatments: Is It Available In The US
  Presenter(s):Elchanan Bruckheimer, MBBS  
10:04 AM - 10:09 AM Holographic Guidance Of Endovascular Procedures: What Is Possible And What Is Not
  Presenter(s):Claude Mialhe, MD  
DUPLEX AND INTRAVASCULAR ULTRASOUND
10:10 AM - 10:15 AM Duplex Ultrasound Guidance: How, Where And When Can It Replace Fluoroscopy For Endovascular Procedures: Advantages, Limitations, And Why Its Use Is Increasing
  Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM  
10:16 AM - 10:21 AM Intravascular Ultrasound (IVUS) Assistance In EVAR And TEVAR: Advantages And Limitations - Based On A Multicenter Study
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
10:22 AM - 10:28 AM Panel Discussion
IMPROVED IMAGING
10:28 AM - 10:33 AM Contrast Induced Nephropathy Is Over-Exaggerated: When Patients Need A Contrast Study, They Should Get It: How To Minimize Consequences
  Presenter(s):Lindsay Machan, MD  
10:34 AM - 10:39 AM Dual Fluoroscopy With Live Image Digital Zooming: How Does It Work And Why Does It Decrease Radiation During Complex AAA Repairs: What Is Its Cost
  Presenter(s):Carlos H. Timaran, MD  
10:40 AM - 10:45 AM Cydar Medical System’s Evolution To Facilitate Fusion With All Digital Fluoroscopes: How The System Uses AI To Improve EVAR Planning, Guidance And Deployment
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
10:46 AM - 10:51 AM The Cydar System Deformation Tool For Improving Image Fusion Accuracy: How Does It Work And Why Does It Help
  Presenter(s):Cynthia K. Shortell, MD  
10:52 AM - 10:57 AM The Cydar System’s Value In Standard And Complex EVAR
  Presenter(s):Venkatesh G. Ramaiah, MD  
10:58 AM - 11:05 AM Panel Discussion
END OF SESSION 89
 
SESSION 90 SCHEDULE
Friday
SESSION 90: CHALLENGING RECORDED LIVE CASES FROM THE MAYO CLINIC AND THE UNIVERSITY OF TEXAS, HOUSTON
x
11:05 AM - 12:00 PM PROGRAM TBD
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 90
 
SESSION 91 SCHEDULE
Friday
SESSION 91: ONE PRESENTATION AND CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY
x
1:00 PM - 1:36 PM Complex Cases From Münster With Questions And Discussion
  Presenter(s):Giovanni B. Torsello, MD / Martin J. Austermann, MD  
1:37 PM - 1:43 PM One Year Results Of The EMINENT RCT Comparing The Eluvia DES Versus Bare Metal Stents
  Presenter(s):Giovanni B. Torsello, MD  
END OF SESSION 91
 
SESSION 92 SCHEDULE
Friday
SESSION 92: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
x
1:44 PM - 1:49 PM New Developments In The Treatment Of Neurogenic TOSs: What Preop Factors Correlate With Good Outcomes; With Bad Outcomes
  Presenter(s):Karl A. Illig, MD  
1:50 PM - 1:55 PM Supraclavicular Approach To Arterial And Neurogenic TOSs (Video Presentation)
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
VENOUS TOSs
1:56 PM - 2:01 PM Venous TOSs: Lessons Learned After Treating >1000 Cases
  Presenter(s):Robert W. Thompson, MD  
2:02 PM - 2:07 PM Spectrum Of Treatment Options For Venous TOS: What Are The Outcomes And How Do They Differ
  Presenter(s):Jason T. Lee, MD  
2:08 PM - 2:13 PM Venography And Balloon Angioplasty For Neurogenic Thoracic Outlet Syndrome: A New Diagnostic And Therapeutic Approach
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
2:14 PM - 2:19 PM Technical Tips For Optimal Surgical Treatment For Venous TOS
  Presenter(s):Robert W. Thompson, MD  
2:20 PM - 2:26 PM Panel Discussion
2:26 PM - 2:36 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 92
 
SESSION 93 SCHEDULE
Friday
SESSION 93: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
x
ANTIPLATELET REGIMENS
2:36 PM - 2:41 PM Optimal Antiplatelet Management With CEAs, Lower Extremity Bypasses And Open AAA Repairs
  Presenter(s):David H. Stone, MD  
2:42 PM - 2:47 PM Optimal Anticoagulation And Antiplatelet Treatment For High Risk Lower Extremity Bypasses – Vein And PTFE
  Presenter(s):Peter Henke, MD  
2:48 PM - 2:53 PM Most Effective Antiplatelet After Lower Extremity Interventional Treatments For CLTI – POBA, DCBs, Stents, Etc.
  Presenter(s):Maciej L. Dryjski , MD, PhD  
2:54 PM - 2:59 PM Why Clopidogrel Is Effective In <50% Of Patients At Standard Doses: How To Identify And Fix This Problem
  Presenter(s):Karthik Kasirajan, MD  
NEW DEVELOPMENTS IN LIPID MANAGEMENT – STATINS
3:00 PM - 3:05 PM Safety And Benefit Of Statins And Medical Treatment In Vascular Patients: Shockingly These Treatments Are Underutilized – Especially In Women: Why Is This So
  Presenter(s):Christian A. Behrendt, MD  
3:06 PM - 3:11 PM Value Of Statins In AAA Patients After Repair: Long-Term Impact On Mortality
  Presenter(s):Adam Beck, MD  
3:12 PM - 3:17 PM The Importance Of Lipoprotein Little a [Lp(a)] Levels In Determining Atherosclerotic Risk: When Should It Be Measured And If High, How Treated: Do PCSK-9 Inhibitors Help
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
3:18 PM - 3:24 PM Panel Discussion
3:24 PM - 3:29 PM Elevated Neutrophil To Lymphocyte Ratio Predicts Poor Outcomes And Mortality After Elective EVAR And CEA: What Is The Mechanism
  Presenter(s):Jae S. Cho, MD  
3:30 PM - 3:35 PM The Justification For Carotid Screening Is To Promote Medical Treatment To Decrease Stroke And MI Risks, Not To Push Patients To Have Unnecessary Invasive Procedures
  Presenter(s):Kosmas I. Paraskevas, MD  
3:36 PM - 3:41 PM Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: Doing These Things Should Be A Lifetime Goal
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
3:42 PM - 3:47 PM Current (2021) Status Of Diagnosis And Treatment Of Buerger’s Disease: Does It Exist Or Is It Just A Variant Of Atherosclerosis
  Presenter(s):Kamphol Laohapensang, MD  
3:48 PM - 3:53 PM How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
  Presenter(s):James H. Black, III, MD  
3:54 PM - 4:00 PM Panel Discussion
END OF SESSION 93
 
SESSION 94 SCHEDULE
Friday
SESSION 94: ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
Moderators:Timur P. Sarac, MD / Todd E. Rasmussen, MD, FACS / TBD  
x
4:00 PM - 4:05 PM Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA): When Is It A Valuable Procedure And When Is It Not: Limitations And Precautions
  Presenter(s):Gilbert R. Upchurch, MD  
4:06 PM - 4:11 PM Value Of REBOA For Pending And Actual Cardiac Arrest: What Is Partial And Intermittent REBOA And How Is It Helpful
  Presenter(s):Tal M. Hoerer, MD, PhD  
4:12 PM - 4:17 PM Value Of Simulator Based Training For REBOA: How Does It Work: Can It Improve Results And Decrease Mishaps
  Presenter(s):Lars B. Lonn, MD, PhD  
4:18 PM - 4:23 PM Transexamic Acid – An Antifibrinolytic Drug: Does It Reduce Mortality With Mild To Moderate Traumatic Brain Injuries: Based On A RCT
  Presenter(s):Todd E. Rasmussen, MD, FACS  
4:24 PM - 4:29 PM Why One Should Have A Stock On Hand Of Balloon-Expandable And Self-Expandable Covered Stents To Deal With Emergencies From Iatrogenic And Other Traumatic Vascular Injuries: What Should Be In The Stock
  Presenter(s):Maria A. Ruffino, MD, EBIR  
4:30 PM - 4:35 PM Radial Access Techniques And Technology For Embolotherapy To Treat Vascular Trauma: Indications And Results
  Presenter(s):Jonathan J. Morrison, PhD, FRCS  
4:36 PM - 4:41 PM For Major Venous Injuries: Repair Versus Ligation – Which Is Currently Best When
  Presenter(s):Samy S. Nitecki, MD  
4:42 PM - 4:47 PM Update On Best Current Management Of Pediatric Vascular Injuries: When Conservative; When Open; When Endo And Precautions
  Presenter(s):Michael C. Dalsing, MD  
4:48 PM - 4:54 PM Panel Discussion
BLUNT THORACIC AORTIC INJURY (BTAI)
4:54 PM - 4:59 PM Endovascular Repairs Of Traumatic Aortic Injuries – Civilian And Military: Technology, Technical Tips And Results
  Presenter(s):James W. Dennis, MD  
5:00 PM - 5:05 PM When Can Minor BTAI Be Treated By Observation Without TEVAR: What Precautions Are Necessary
  Presenter(s):Elina Quiroga, MD, MPH  
5:06 PM - 5:11 PM DEBATE: Are We Overtreating BTAI – Especially Lesser Injuries
  Presenter(s):Joseph J. DuBose, MD  
5:12 PM - 5:17 PM DEBATE: Why Many Patients With Lesser Degrees Of BTAI Require TEVAR
  Presenter(s):Ali Azizzadeh, MD  
5:18 PM - 5:23 PM Why Rapid And Complete Aortic Healing After TEVAR For BTAI Should Influence The Length And Diameter Of The Endograft Used: Oversizing And Length Of Seal Zone Can Be Minimized: Technical Tips
  Presenter(s):Shang Loh, MD  
5:24 PM - 5:29 PM How To Manage Heparin In TEVAR For BTAI When Head Or Other Injuries Are Also Present: Some, None Or Just Sheath Flushing
  Presenter(s):Charles J. Fox, MD, FACS  
5:30 PM - 5:35 PM With TBAI Requiring TEVAR, When Can The Left Subclavian Artery Be Covered And When Not: Tips On Endograft Sizing
  Presenter(s):Elina Quiroga, MD, MPH  
5:36 PM - 5:42 PM Panel Discussion
End of Program L

END OF SESSION 94
 
SESSION 95 SCHEDULE
Friday
SESSION 95: PELVIC VENOUS DISORDERS, FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
x
7:00 AM - 7:04 AM Introduction: Deep System
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
7:05 AM - 7:10 AM Iliocaval Duplex Ultrasound With Image Optimization
  Presenter(s):Jan M. Sloves, RVT  
7:11 AM - 7:16 AM PTS Patients: Identifying Patients Most Likely To Fail Stenting
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
7:17 AM - 7:22 AM Venographic Techniques To Identify Pelvic Anatomy And Escape Points
  Presenter(s):Mark H. Meissner, MD  
7:23 AM - 7:28 AM Ovarian Vein Embolization: Which Patient Benefits And Reimbursement
  Presenter(s):Kathleen D. Gibson, MD  
7:29 AM - 7:34 AM Open Surgery For Nutcracker: Techniques And Results
  Presenter(s):Cynthia K. Shortell, MD  
7:35 AM - 7:40 AM We Need Dedicated Venous Stents For Nutcracker Syndrome And We Need Them Now
  Presenter(s):Peter Gloviczki, MD  
7:41 AM - 7:46 AM Panel Discussion
CHRONIC VENOUS OBSTRUCTION
Moderator(s): Jose I. Almeida, MD, FACS, RPVI, RVT / Patrick E. Muck, MD, FACS  
7:47 AM - 7:52 AM Recanalizing Occluded Venous Stents
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:53 AM - 7:58 AM Deep Reflux: What Happens After Concomitant Obstruction Correction
  Presenter(s):Marzia Lugli, MD  
7:59 AM - 8:04 AM Contralateral Limb Improvement After Unilateral Iliac Vein Stenting: Argument Against Simultaneous Bilateral Stenting
  Presenter(s):Seshadri Raju, MD  
8:05 AM - 8:10 AM CAVA Trial Lessons Learned About Post Thrombotic Syndrome
  Presenter(s):Cees H.A. Wittens, MD, PhD  
8:11 AM - 8:16 AM Utilizing The Radiofrequency Power Wire To Vaporize A Channel Through Chronic Iliocaval Venous Obstructions (CICVO)
  Presenter(s):Patrick E. Muck, MD, FACS  
8:17 AM - 8:22 AM Panel Discussion
END OF SESSION 95
 
SESSION 96 SCHEDULE
Friday
SESSION 96: FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
x
8:23 AM - 8:28 AM Impact Of Stent Structure On Venous Flow (In Vitro Investigations With A Designed Fluid Dynamic Model)
  Presenter(s):Houman Jalaie, MD, PhD  
8:29 AM - 8:34 AM Does Vein Stenting Reduce Great And Small Saphenous Venous Reflux
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM  
8:35 AM - 8:40 AM Misconceptions Regarding Elastic Compression For Prevention Of Post-Thrombotic Changes
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
8:41 AM - 8:46 AM Best Anticoagulation After Deep Venous Stenting
  Presenter(s):Ellen D. Dillavou, MD  
8:47 AM - 8:52 AM Appropriate Iliofemoral Venous Stent Sizing
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
8:53 AM - 8:58 AM Outcomes And Predictors Of Failure Of Iliac Vein Stenting
  Presenter(s):Rabih A. Chaer, MD  
8:59 AM - 9:04 AM Reinterventions Following Vein Stent Placements – Lessons Learned From 166 Cases
  Presenter(s):Windsor Ting, MD  
9:05 AM - 9:10 AM Panel Discussion
END OF SESSION 96
 
SESSION 97 SCHEDULE
Friday
SESSION 97: HYBRID TECHNIQUES, STENT PROBLEMS, POST-IMPLANTATION
x
9:11 AM - 9:16 AM Endovascular Remote Endovenectomy For Chronic Venous Disease Using The Inari CloTriever
  Presenter(s):Steven D. Abramowitz, MD  
9:17 AM - 9:22 AM Neointima Formation Following Venous Placement Of Self-Expanding Nitinol Stents Of Different Porosity: Clinical And Experimental Results
  Presenter(s):Houman Jalaie, MD, PhD  
9:23 AM - 9:28 AM Biopsy Of Venous In-Stent Stenosis: Histopathology And Treatment
  Presenter(s):David M. Williams, MD  
9:29 AM - 9:34 AM Utilizing Indigo System To Extract Thrombus Prior To ISR Ballooning And Stenting: Our Institution’s Experience
  Presenter(s):Frank R. Arko, MD  
9:35 AM - 9:40 AM CAVA Trial: Long-Term Follow-Up
  Presenter(s):Cees H.A. Wittens, MD, PhD  
9:41 AM - 9:46 AM Endovectomy And Iliac Vein Stent Placement: How I Do It (Video Technique Demonstration)
  Presenter(s):Houman Jalaie, MD, PhD  
9:47 AM - 9:52 AM Iatrogenic Balloon Laceration O Central Vein: Now What
  Presenter(s):Gerard J. O'Sullivan, MD  
9:53 AM - 9:58 AM Techniques For Endovenectomy And Concomitant Iliocaval Stenting With And Without Adjuvant Arteriovenous Fistula Creation
  Presenter(s):Steven D. Abramowitz, MD  
9:59 AM - 10:04 AM Panel Discussion
END OF SESSION 97
 
SESSION 98 SCHEDULE
Friday
SESSION 98: STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION, WOUNDS, MEDICINES, AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
x
10:05 AM - 10:10 AM What To Do When Iliac Vein Stenting As Well As Endovenous Ablation Fail To Heal The Venous Ulcer: Tips And Tricks
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
10:11 AM - 10:16 AM When Deep Venous Reflux Repair Is Not Effective: What Next
  Presenter(s):Marzia Lugli, MD  
10:17 AM - 10:22 AM Evolution Of Endovenous Treatment Options For Acute DVT
  Presenter(s):Antonios P. Gasparis, MD  
10:23 AM - 10:28 AM A Look At ABRE Stent Occlusions From The IDE Trial: Key Takeaways
  Presenter(s):Erin H. Murphy, MD  
10:29 AM - 10:34 AM Management Options Of Infrainguinal Disease: Indications And Options
  Presenter(s):Steve Elias, MD  
10:35 AM - 10:40 AM Panel Discussion
WOUNDS AND NEW HORIZONS
Moderator(s): Peter F. Lawrence, MD / William A. Marston, MD  
10:41 AM - 10:46 AM What Is The Standard Of Care For Venous Wounds
  Presenter(s):William A. Marston, MD  
10:47 AM - 10:52 AM Skin Substitutes To Promote Venous Leg Ulcer Healing
  Presenter(s):Sarah Onida, MD, PhD  
10:53 AM - 10:58 AM Treatment Of Superficial And Perforator Reflux And Deep Venous Stenosis Improves Healing Of Chronic Venous Leg Ulcers
  Presenter(s):Peter F. Lawrence, MD  
10:59 AM - 11:04 AM Do The EVRA Study Results Apply For Ulcers >6 Months Chronicity
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
11:05 AM - 11:10 AM The Economic Impact Of Infections In Venous Leg Ulcer Patients
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
11:11 AM - 11:16 AM Panel Discussion
END OF SESSION 98
 
SESSION 99 SCHEDULE
Friday
SESSION 99: VENOUS STENT TRIALS AND CONCEPTS
x
11:17 AM - 11:22 AM Differences Between Elgiloy And Nitinol Stents
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
11:23 AM - 11:28 AM Virtus Trial - 3-Year Update
  Presenter(s):William A. Marston, MD  
11:29 AM - 11:34 AM Vernacular Trial - 3-Year Update
  Presenter(s):Gerard J. O'Sullivan, MD  
11:35 AM - 11:40 AM ABRE Trial Results
  Presenter(s):Stephen A. Black, MD  
11:41 AM - 11:46 AM Zilver Vena Stent Trial
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
11:47 AM - 11:52 AM What Can The Arnsberg Registry Tell Us
  Presenter(s):Michael K.W. Lichtenberg, MD  
11:53 AM - 11:58 AM What Is Aspect Ratio And What Does The Clinical Data Reveal
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
11:59 AM - 12:04 PM Aspect Ratio Of Iliac Stenosis: Does It Matter
  Presenter(s):Seshadri Raju, MD  
12:05 PM - 12:10 PM Panel Discussion
12:10 PM - 12:40 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 99
 
SESSION 100 SCHEDULE
Friday
SESSION 100: MORE ILIOFEMORAL FLOW AND PELVIC ISSUES
x
12:40 PM - 12:45 PM Do Venous Stent Fractures Matter
  Presenter(s):David J. Dexter, MD  
12:46 PM - 12:51 PM Treatment Algorithm For Pelvic Venous Reflux
  Presenter(s):Antonios P. Gasparis, MD  
12:52 PM - 12:57 PM Which Is More Important: Pelvic Venous Insufficiency Or Iliac Vein Obstruction
  Presenter(s):Peter J. Pappas, MD  
12:58 PM - 1:03 PM Male Pelvic Congestion And Varicose Veins: How Much Of A Problem
  Presenter(s):Mark S. Whiteley, MS, FRCS  
1:04 PM - 1:09 PM The SVP Classification Of Pelvic Venous Disorders
  Presenter(s):Neil M. Khilnani, MD  
1:10 PM - 1:15 PM A Novel Technique And Outcomes For Iliocaval Extravascular Reconstruction (TIER) For Iliocaval Agenesis
  Presenter(s):Steven D. Abramowitz, MD  
1:16 PM - 1:21 PM Deep Venous Reconstruction: Is It Safe And Profitable In An OBL
  Presenter(s):Paul J. Gagne, MD  
1:22 PM - 1:27 PM Panel Discussion
END OF SESSION 100
 
SESSION 101 SCHEDULE
Friday
SESSION 101: STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM
x
VTE INTERVENTIONAL
1:28 PM - 1:33 PM DVT Removal Without Thrombolytics – Mechanical Thrombectomy Is Now The Standard Of Care For Both Upper And Lower Extremity DVT
  Presenter(s):Patrick E. Muck, MD, FACS  
1:34 PM - 1:39 PM P-Max Study: Mechanical Thrombectomy For Iliofemoral DVT With Aspirex
  Presenter(s):Michael K.W. Lichtenberg, MD  
1:40 PM - 1:45 PM Thrombolysis For Acute DVT: Utilization And Guidance From Current Clinical Trials
  Presenter(s):Brian G. DeRubertis, MD  
1:46 PM - 1:51 PM A Comparison Of Angiojet Versus CDT For The Treatment Of Iliofemoral DVT
  Presenter(s):Stephen A. Black, MD  
1:52 PM - 1:57 PM Angiovac Venous Thrombectomy: Where, When, And How
  Presenter(s):David J. Dexter, MD  
1:58 PM - 2:03 PM Venous Aneurysms: Should They Be Treated
  Presenter(s):Peter F. Lawrence, MD  
2:04 PM - 2:09 PM Renal Failure In Acute DVT Treatment: Incidence And Strategies For Prevention
  Presenter(s):Stephen A. Black, MD  
2:10 PM - 2:15 PM Clot Registry For The Inari CloTriever
  Presenter(s):David J. Dexter, MD  
2:16 PM - 2:21 PM Panel Discussion
CENTRAL VENOUS THROMBOSIS; COVID-19
Moderator(s): Steve Elias, MD / Mikel Sadek, MD  
2:22 PM - 2:27 PM Technical Properties Of Nitinol
  Presenter(s):Erin H. Murphy, MD  
2:28 PM - 2:33 PM Does PMT Now Lead To Over-Stenting
  Presenter(s):Stephen A. Black, MD  
2:34 PM - 2:39 PM ABRE 24-Month Study Data
  Presenter(s):Erin H. Murphy, MD  
2:40 PM - 2:45 PM COVID-19: What Have We Learned – China Experience
  Presenter(s):Wang Jinsong Wang, MD  
2:46 PM - 2:51 PM COVID-19 Treatment Of Venous Thrombosis In Hospitalized Patients
  Presenter(s):Mikel Sadek, MD  
2:52 PM - 2:57 PM COVID-19 Outpatient Experience With Anticoagulation
  Presenter(s):Steve Elias, MD  
2:58 PM - 3:03 PM COVID-19 And Thrombotic Or Thromboembolic Disease: Implications For Prevention, Antithrombotic Therapy, And Follow-Up
  Presenter(s):Joseph A. Caprini, MD  
3:04 PM - 3:09 PM Panel Discussion
Moderator(s): Anthony J. Comerota, MD, FACS, FACC / Peter Henke, MD  
3:10 PM - 3:15 PM Using The Femoral Vein As A Tunneling Conduit For An Arterial Bypass: Venous Outcomes In PQ Bypass
  Presenter(s):Mark A. Adelman, MD  
3:16 PM - 3:21 PM Duration Of Anticoagulation
  Presenter(s):Rachel Rosovsky, MD, MPH  
3:22 PM - 3:27 PM Should All Patients With Acute VTE Be Treated With A Statin: When And Dose
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
3:28 PM - 3:33 PM Update On Reversal Agents For The DOACs
  Presenter(s):Timothy K. Liem, MD, MBA  
3:34 PM - 3:39 PM Thrombus Aging Using MRI
  Presenter(s):Stephen A. Black, MD  
3:40 PM - 3:45 PM Role Of Thrombophilia Testing
  Presenter(s):Rachel Rosovsky, MD, MPH  
3:46 PM - 3:51 PM Update In Experimental DVT Pathogenesis And Resolution
  Presenter(s):Peter Henke, MD  
3:52 PM - 3:57 PM DOAC Revolution – Which Drug For What Disease: Review Of Ongoing Trials
 
3:58 PM - 4:03 PM Pediatric DVT: An Evidence Summary
  Presenter(s):Dawn M. Coleman, MD  
4:04 PM - 4:09 PM Inflammation And Venous Thrombosis: An Evidence Summary
  Presenter(s):Thomas W. Wakefield, MD  
4:10 PM - 4:15 PM Family History Of Thrombosis: The Forgotten Risk Factor
  Presenter(s):Joseph A. Caprini, MD  
4:16 PM - 4:21 PM Current Strategy Of VTE Prevention In China
  Presenter(s):Wang Jinsong Wang, MD  
4:22 PM - 4:27 PM Mesenteric Vein Thrombosis: What Is The Best Strategy
  Presenter(s):Mark G. Davies, MD  
4:28 PM - 4:33 PM Thoracic Outlet Acute VTE: What To Do And When
  Presenter(s):Saum A. Rahimi, MD  
4:34 PM - 4:39 PM Closed Plication Is A Safe And Effective Method For Treating Popliteal Venous Aneurysm
  Presenter(s):Thomas W. Wakefield, MD  
4:40 PM - 4:45 PM Panel Discussion
END OF SESSION 101
 
SESSION 102 SCHEDULE
Friday
SESSION 102: DEEP VEIN VALVE TECHNOLOGIES, CAVAL INTERRUPTION
x
DEEP VALVE PROGRESS
4:46 PM - 4:51 PM The Need For A Deep Venous Valve For Severe CVI Patients With DVT
  Presenter(s):Mikel Sadek, MD  
4:52 PM - 4:57 PM Safety And Efficacy Report On The Venovalve (First In Man) IDE Feasibility Study
  Presenter(s):Jorge H. Ulloa, MD, FACS  
4:58 PM - 5:03 PM US Experience Of The BlueLeaf®Endovenous Valve Formation: Update
  Presenter(s):William A. Marston, MD  
5:04 PM - 5:09 PM Implantable Bicuspid Valve: Early Preclinical Results
  Presenter(s):Paul J. Gagne, MD  
5:10 PM - 5:15 PM Surgical Creation Of A Monocusp Valve
  Presenter(s):Marzia Lugli, MD  
5:16 PM - 5:21 PM Panel Discussion
CAVAL INTERRUPTION
Moderator(s): Timothy K. Liem, MD, MBA / Jose I. Almeida, MD, FACS, RPVI, RVT  
5:22 PM - 5:27 PM What To Do With Fractured Filters And Embolic Filter Fragments
  Presenter(s):Constantino Pena, MD  
5:28 PM - 5:33 PM Thrombosed IVC Filter: How To Recanalize The Cava And Manage The Filter
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
5:34 PM - 5:39 PM IVC Management In Pregnant Patients
  Presenter(s):Joann Lohr, MD  
5:40 PM - 5:45 PM Surgical Removal Of IVC Filters: Perforation Or Infiltration
  Presenter(s):Timothy K. Liem, MD, MBA  
5:46 PM - 5:51 PM Why Temporary Filters Are Not Removed: Clinical Predictors In 1,000 Consecutive Cases
  Presenter(s):Heron E. Rodriguez, MD  
5:52 PM - 6:03 PM Panel Discussion
End of Program M

END OF SESSION 102
 
SESSION 103 SCHEDULE
Saturday
SESSION 103: LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
x
7:00 AM - 7:05 AM Optimal Vessel Prep Is Key To Successful BTK And Tibial Angioplasty (PTA): How To Do It
  Presenter(s):Peter A. Schneider, MD  
7:05 AM - 7:10 AM Why Endovascular Treatments Should Be The First Choice For Common Femoral Artery (CFA) Occlusive Lesions
  Presenter(s):Niten Singh, MD  
7:10 AM - 7:15 AM Technical Tips For Retrograde Tibial And Pedal Access Under Ultrasound (Duplex) Guidance: Contraindications When Fluoro Is Better
  Presenter(s):Steven Kum, MD  
7:15 AM - 7:20 AM What Is The Real Complication Rate With Retrograde Tibial And Pedal Access: How To Minimize These Complications
  Presenter(s):Michael H. Wholey, MD, MBA  
7:20 AM - 7:25 AM DEBATE: An Endo First Approach Is Best For Treating CLTI In All Patients: Is There Any Role For Open Bypasses
  Presenter(s):Christopher J. Abularrage, MD  
7:25 AM - 7:30 AM DEBATE Not So: Open Bypass Should Be The First Treatment For Some CLTI Patients: When Is This So And In What Percentage Of CLTI Patients
  Presenter(s):Karan Garg, MD  
7:30 AM - 7:35 AM Panel Discussion
ATHERECTOMY RELATED TOPICS
7:35 AM - 7:40 AM Value Of Atherectomy And Other Technologies In Heavily Calcified Infrapopliteal Lesions For CLTI: Which Lesions To Treat And What Do We Know About Their Impact
  Presenter(s):Venita Chandra, MD  
7:40 AM - 7:45 AM Are Isolated Pedal Interventions For CLTI Worthwhile
  Presenter(s):Mark G. Davies, MD  
7:45 AM - 7:50 AM DEBATE: Multivessel Tibial Revascularization Does Not Improve Limb Salvage In CLTI Patients: From A VQI Study
  Presenter(s):Venita Chandra, MD  
7:50 AM - 7:55 AM DEBATE: Not So: In Some Circumstances Multivessel Tibial Revascularization Does Improve Outcomes In CLTI Patients: Which Circumstances
  Presenter(s):Brian G. DeRubertis, MD  
7:55 AM - 8:00 AM Panel Discussion
8:00 AM - 8:05 AM Indication And Technical Tips For Performing Retrograde Popliteal Artery Access
  Presenter(s):Jeffrey J. Siracuse, MD  
8:05 AM - 8:10 AM Prograde SFA Access Can Be Safe And Effective For Lower Extremity Endo Procedures; When And How To Do It
  Presenter(s):Todd Berland, MD  
8:10 AM - 8:15 AM Technical Tips For Open Tibial And Pedal Artery Exposures In Virginal And Redo Situations
  Presenter(s):William P. Robinson, MD  
8:15 AM - 8:20 AM When Are Oral Antibiotics Without Excision Of Infected Bone Adequate Treatment For Osteomyelitis In The Foot
  Presenter(s):Wayne J. Caputo, DPM  
8:20 AM - 8:25 AM Panel Discussion
END OF SESSION 103
 
SESSION 104 SCHEDULE
Saturday
SESSION 104: MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
x
8:25 AM - 8:30 AM Technical Tips For Retrograde Access Via The SFA, Popliteal And BTK Arteries: When And How To Do It
  Presenter(s):Lorenzo Patrone, MD  
8:30 AM - 8:35 AM Dangers And Pitfalls Of Retrograde Lower Extremity Access Distal To The Common Femoral Artery
  Presenter(s):Venita Chandra, MD  
8:35 AM - 8:40 AM Impact Of A Dedicated Limb Preservation/Limb Salvage Service On Amputation Rates: Must It Include An Open Bypass Surgery Component
  Presenter(s):Niten Singh, MD  
8:40 AM - 8:45 AM Importance Of Functional And Ambulatory Status In Decision Making In CLTI Patients: Why Limbs Should Be Saved In Patients Who Are Not Ambulatory
  Presenter(s):Vincent L. Rowe, MD  
8:45 AM - 8:50 AM Endo Versus Open Reinterventions To Assist In Maintaining Patency Of Distal Vein Grafts: Both Are Needed
  Presenter(s):Francesco Spinelli, MD  
8:50 AM - 8:55 AM Panel Discussion
8:55 AM - 9:00 AM Relationship Between Zinc Deficiency And The Outcomes Of Lower Extremity Bypasses For CLTI: Should All CLTI Patients Be Given Zinc
  Presenter(s):Kimihiro Komori, MD, PhD  
9:00 AM - 9:05 AM Open Versus Endo Revascularizations In Dialysis Patients With CLTI: What Is The Role Of Each
  Presenter(s):Rabih A. Chaer, MD  
9:05 AM - 9:10 AM What Is The Best Vessel Prep For Endo Treatments Of Heavily Calcified Lesions: Technical Tips And Precautions
  Presenter(s):Theodosios Bisdas, MD  
9:10 AM - 9:15 AM Real World Outcomes With Zilver PTX DESs For Complex Fempop Disease: Why Do They Differ From Trial Results
  Presenter(s):Ali F. AbuRahma, MD  
9:15 AM - 9:25 AM Panel Discussion
9:25 AM - 9:30 AM Value Of Duplex Gray Scale In Predicting Successful SFA CTO Crossing, Re-Entry And The Need For Distal Access
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM  
9:30 AM - 9:35 AM Effect Of Short-Term Complications Of Lower Extremity Revascularizations On Long-Term Outcomes And Patient Survival
  Presenter(s):Joseph L. Mills, MD  
9:35 AM - 9:40 AM Endovascular Diagnosis And Control f Hemorrhage After Fempop Open Operations: It Is A Better Way And How To Do It
  Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD  
9:40 AM - 9:45 AM Longer Procedure Times Are Predictive Of Worse Outcomes With Endovascular Treatments Of Lower Extremity Occlusive Lesions
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
9:45 AM - 9:50 AM Panel Discussion
9:50 AM - 10:00 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 104
 
SESSION 105 SCHEDULE
Saturday
SESSION 105: NEW DEVELOPMENTS IN COVID-19 TREATMENTS AND THE EFFECTS OF COVID-19 ON THE VASCULAR SYSTEM
x
10:00 AM - 10:05 AM Patients With AAAs Who Had COVID-19 May Need More Frequent Surveillance
  Presenter(s):Ronald L. Dalman, MD  
10:06 AM - 10:11 AM What Will Be The Post-Pandemic Steady State Of Novel Infection And Acquired Immunity: Is “Herd Immunity” A Realistic Concept
  Presenter(s):Clayton J. Brinster, MD  
10:12 AM - 10:17 AM Impact Of COVID-19 On The Extra- And Intracranial Circulation: How Effective Are Endovascular Treatments
  Presenter(s):Allan L. Brook, MD  
10:18 AM - 10:23 AM Current Treatment Paradigms For Symptomatic COVID-19 Infection: What Works, What Doesn’t, What’s Available And What’s In The Pipeline
  Presenter(s):Clayton J. Brinster, MD  
10:24 AM - 10:29 AM Endovascular Management Of COVID-19 Induced Acute Limb Ischemia: When Is It Effective And When Not
  Presenter(s):Karthik Kasirajan, MD  
10:30 AM - 10:40 AM Do Current Vaccines Or Previous Infection Protect Against New Variants Of COVID-19: Will Vaccine Boosters Be Required – For Whom And How Often
  Presenter(s):Clayton J. Brinster, MD  
10:41 AM - 10:46 AM The Impact Of COVID-19 On Surgical Training Now And In The Future
  Presenter(s):Celia Riga, MD, FRCS  
10:47 AM - 11:00 AM Panel Discussion
END OF SESSION 105
 
SESSION 106 SCHEDULE
Saturday
SESSION 106: AORTIC TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
x
11:00 AM - 11:05 AM Improved System For Evaluating Aortic Neck Anatomy And Suitability For EVAR And F/EVAR
  Presenter(s):David J. Minion, MD  
11:05 AM - 11:10 AM Top 10 Clinical Trials That Are Needed In AAA Disease
  Presenter(s):Ronald L. Dalman, MD  
SPINE EXPOSURE SURGERY
11:10 AM - 11:17 AM Technical Tips And Tools For The Vascular Surgeon To Provide Anterior Exposure For Spine Procedures (7-Minute Presentation)
  Presenter(s):Jeffrey Jim, MD, MPHS  
11:18 AM - 11:25 AM Vascular Complications Of Anterior Spine Exposures; How To Avoid Them And How To Treat Them If They Occur (7-Minute Presentation)
  Presenter(s):William P. Robinson, MD  
11:25 AM - 11:30 AM EVAR Outside The IFUs Of Commercial Devices Is Sometimes Justified And Does Not Negatively Impact On Midterm Outcomes: When Is This So
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
11:30 AM - 11:35 AM The Aortyx Aortic Patch For Repairing Focal Aortic Defects: How Does It Work And Current Status
  Presenter(s):Vicente Riambau, MD, PhD  
11:35 AM - 11:40 AM Panel Discussion
11:40 AM - 11:45 AM How To Avoid Axillary Artery Complications After Large Sheath Use In Complex AAA Repairs
  Presenter(s):Michael C. Stoner, MD  
11:45 AM - 11:50 AM Late Complications Of F/B/EVAR In An Experience Of >1000 Cases
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
11:50 AM - 11:55 AM With F/EVAR Intraoperative Endoleaks Do No Predict Midterm Failure
  Presenter(s):Michael J. Singh, MD  
11:55 AM - 12:00 PM Left Subclavian Revascularization With TEVAR: Technical Tips And Tools To Make In Situ Fenestration Easy
  Presenter(s):Wayne W. Zhang, MD  
12:00 PM - 12:05 PM Variable Curve Directional Sheaths Will Eliminate The Need For Upper Extremity Access With F/B/EVAR: Which Sheath Is Best And Pitfalls
  Presenter(s):James F. McKinsey, MD  
12:05 PM - 12:10 PM How Can Computer Modeling Help To Improve The Treatment Of TBADs
  Presenter(s):Ross Milner, MD  
12:10 PM - 12:15 PM Panel Discussion
Lunch Available

END OF SESSION 106
 
SESSION 107 SCHEDULE
Saturday
SESSION 107: AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
x
AORTIC TOPICS
12:15 PM - 12:20 PM Options For Managing The Left Subclavian Artery When Performing Endovascular Treatment Of Zone 2 Lesions
  Presenter(s):Edward Y. Woo, MD / Steven D. Abramowitz, MD  
12:20 PM - 12:25 PM Carotid-To-Axillary Bypass Is Better Than Carotid-Subclavian Bypass For Revascularizing Subclavian Arteries With TEVAR: Why And How To Do It
  Presenter(s):Frank J. Criado, MD  
12:25 PM - 12:30 PM When Is A Left Subclavian Chimney Graft Better Than A Carotid-Subclavian Bypass For Preserving Subclavian Artery Flow
  Presenter(s):R. Clement Darling III, MD  
12:30 PM - 12:35 PM Upper Extremity Access For Complex Endo AAA Repairs Is Associated With A High Rate Of Stroke: From A VQI Study
  Presenter(s):Marc L. Schermerhorn, MD  
12:35 PM - 12:40 PM DEBATE: The Vast Majority Of Failed EVARs Can Be Treated Endovascularly
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
12:40 PM - 12:45 PM DEBATE: Not So: Many Failed EVARs Are Best Repaired By Open Conversion
  Presenter(s):Michel Makaroun, MD  
12:45 PM - 12:50 PM AAAs With Large Diameter Necks (>34 mm) Do Poorly With EVAR: How Should Such Patients Be Treated
  Presenter(s):Matt M. Thompson, MD  
12:50 PM - 12:55 PM Value Of 3D Flow Models To Analyze The Cause Of Failure After F/EVAR And TEVAR
  Presenter(s):Maciej L. Dryjski , MD, PhD  
12:55 PM - 1:00 PM Panel Discussion
CAROTID TOPICS
1:00 PM - 1:05 PM Optimal Anticoagulant And Antiplatelet Treatment For Symptomatic And Asymptomatic Patients With Carotid Stenosis
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
1:05 PM - 1:10 PM How To Use The Silk Road TCAR Device In The Treatment Of Tandem Carotid Lesions: Technical Tips And Results
  Presenter(s):Michael C. Stoner, MD  
1:10 PM - 1:15 PM Radiation And Carotid Stenosis: What Is The Relationship And How Is Radiation Stenosis Best Treated When Asymptomatic And When Symptomatic
  Presenter(s):Cynthia K. Shortell, MD  
1:15 PM - 1:20 PM Mini-Incision CEA With Standard Or Eversion Techniques: How To Do It Safely: It’s Better Than Transfemoral CAS Or TCAR
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
1:20 PM - 1:25 PM TCAR With Flow Reversal Versus Transcervical CAS With Distal Protection: TCAR’s Benefit Is Not Just Due To Its Avoidance Of Having To Traverse The Aortic Arch
  Presenter(s):Mahmoud B. Malas, MD, MHS  
1:25 PM - 1:30 PM Panel Discussion
End of Program N

END OF SESSION 107
 
SESSION 108 SCHEDULE
Saturday
SESSION 108: IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
x
8:00 AM - 8:05 AM Introduction
  Presenter(s):Anton N. Sidawy, MD, MPH / Larry A. Scher, MD  
8:06 AM - 8:13 AM What Vascular Access Issues Are Important To Patients
  Presenter(s):Dori R. Schatell, MS  
8:14 AM - 8:21 AM Where Should Patients And Physicians Get Information About Hemodialysis Access
  Presenter(s):Ellen D. Dillavou, MD  
8:22 AM - 8:29 AM Kickstarting Your Peritoneal Dialysis Program
  Presenter(s):Sean D. Kalloo, MD  
8:30 AM - 8:37 AM Update On The Use Of Fist Assist To Maximize Creation And Maturation Of Autogenous AV Fistula
 
8:38 AM - 8:45 AM Surgical Management Of The Mega Fistula
  Presenter(s):John R. Ross, Sr., MD  
8:46 AM - 8:53 AM Cardiovascular Implantable Electronic Devices In Hemodialysis Patients: Prevalence And Strategies For Management
  Presenter(s):Theodore F. Saad, MD  
8:54 AM - 9:04 AM Panel Discussion
9:05 AM - 9:12 AM Body Image, Sexuality And Hemodialysis Access
  Presenter(s):Dori R. Schatell, MS  
9:13 AM - 9:20 AM Options For Management Of Deep AV Fistulas
  Presenter(s):William Jennings, MD  
9:21 AM - 9:28 AM Managing The Pulsatile AV Access: How To Prolong Access Life
  Presenter(s):Surendra Shenoy, MD, PhD  
9:29 AM - 9:36 AM Use Of Drug Eluting Balloons And Stents: What Does The Data Tell Us
  Presenter(s):Theodore F. Saad, MD  
9:37 AM - 9:44 AM LIMA Steal Syndrome After Ipsilateral AV Fistula: Is It Real
  Presenter(s):Jeffrey E. Indes, MD  
9:45 AM - 9:52 AM Early Banding For High Flow AV Fistulas
  Presenter(s):Moro Salifu, MD  
9:53 AM - 10:03 AM Panel Discussion
10:04 AM - 10:25 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 108
 
SESSION 109 SCHEDULE
Saturday
SESSION 109: MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
x
10:26 AM - 10:33 AM Performance Of Vascular Access Procedures During A Global Pandemic
  Presenter(s):Haimanot (Monnie) Wasse, MD, MPH, FASN  
10:34 AM - 10:41 AM Surgeon’s Perspective On Management Of Acute Kidney Injury During The COVID-19 Pandemic
  Presenter(s):Clifford M. Sales, MD, MBA, FACS  
10:42 AM - 10:49 AM How Has COVID-19 Impacted Medicare Reimbursement
  Presenter(s):Evan C. Lipsitz, MD, MBA  
10:50 AM - 10:57 AM Does A High Bifurcation Brachial Artery Affect Outcomes For AV Fistulas And Grafts
  Presenter(s):John S. Futchko, MD  
10:58 AM - 11:05 AM Accelerating Technology Development During A Pandemic To Bring More People With Kidney Failure Home
  Presenter(s):Prabir Roy-Chaudhury, MD, PhD  
11:06 AM - 11:16 AM Panel Discussion
THE USE OF ULTRASOUND IN CONTEMPORARY DIALYSIS ACCESS PRACTICE
Moderator(s): John E. Aruny, MD / Clifford M. Sales, MD, MBA, FACS  
11:17 AM - 11:24 AM Preoperative Vessel Mapping: Did KDOQI Really Make This Optional
  Presenter(s):Charmaine Lok, MD  
11:25 AM - 11:32 AM Economic And Clinical Impact Of Changes In Reimbursement For Predialysis Duplex Planning
  Presenter(s):Jason K. Wagner, MD  
11:33 AM - 11:40 AM Incorporating Point Of Care Ultrasound Into The Practice Of Nephrology
  Presenter(s):Vandana D. Niyyar, MD  
11:41 AM - 11:48 AM Use Of IVUS For Evaluation And Sizing Of Central Vein Stenosis
  Presenter(s):John E. Aruny, MD  
11:49 AM - 12:00 PM Panel Discussion
12:00 PM - 12:50 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 109
 
SESSION 110 SCHEDULE
Saturday
SESSION 110: POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7- 10-MINUTE TALKS)
x
12:50 PM - 12:57 PM Creating AV Fistulas For Children In Guatemala
  Presenter(s):William Jennings, MD  
12:58 PM - 1:05 PM How Will Government Initiatives Move Patients From Dialysis Centers To Home Dialysis
  Presenter(s):Sean D. Kalloo, MD  
1:06 PM - 1:13 PM Implementing The Results Of A Randomized Trial Comparing Early Cannulation Grafts To Catheters Into Practice
  Presenter(s):David Kingsmore, MD, FRCS (Ed), MBChB, BMedBiol  
1:14 PM - 1:24 PM How Artificial Kidneys And Miniaturized Dialysis Could Save Millions Of Lives
  Presenter(s):Buddy D. Ratner, PhD  
1:25 PM - 1:35 PM Keynote Speaker: Health And Human Services Initiatives To Improve Management Of Kidney Disease: A $35 Billion Innovation Black Hole
  Presenter(s):Ed Simcox, JD  
1:36 PM - 1:46 PM Panel Discussion
END OF SESSION 110
 
SESSION 111 SCHEDULE
Saturday
SESSION 111: NEW TECHNOLOGIES AND OTHER IMPORTANT CLINICAL ISSUES IN AV ACCESS (7-MINUTE TALKS)
x
1:47 PM - 1:54 PM Use Of External Support Devices To Improve AV Fistula Maturation
  Presenter(s):Ellen D. Dillavou, MD  
1:55 PM - 2:02 PM Use Of Pharmacologic Adjuncts To Improve AV Fistula Maturation
  Presenter(s):Alan Dardik, MD, PhD  
2:03 PM - 2:10 PM DEBATE: Will EndoAV Fistulas Ever Become The Gold Standard: EndoAV Fistula Is Better Than Surgery
  Presenter(s):Neghae Mawla, MD, FASDIN  
2:11 PM - 2:18 PM DEBATE: Will EndoAV Fistulas Ever Become The Gold Standard: Surgery Is Still The Gold Standard
  Presenter(s):John R. Ross, Sr., MD  
2:19 PM - 2:26 PM Cannulation Issues With Endovascular Fistulas
  Presenter(s):Deborah Brouwer-Maier, RN, CNN  
2:27 PM - 2:34 PM A Non-Biologic Vascular Prosthesis That Heals And Integrates: Application For Dialysis Blood Access And Small Diameter Sites
  Presenter(s):Buddy D. Ratner, PhD  
2:35 PM - 2:42 PM What Is The Best Option For Cephalic Arch Stenosis
  Presenter(s):Mark G. Davies, MD  
2:43 PM - 2:50 PM Management Of The Abandoned HeRO Device
  Presenter(s):Stephen E. Hohmann, MD  
2:51 PM - 2:58 PM HeRO Graft With ARtegraft Attachment For Hemodialysis Access: What Are The Outcomes
  Presenter(s):Jesse Garcia, MD  
2:59 PM - 3:06 PM WRAPSODY™ Endovascular Stent Graft (Merit Medical) For Treatment Of Hemodialysis Access Outflow Stenosis
 
3:07 PM - 3:25 PM Panel Discussion
End of Program O

END OF SESSION 111